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INTRODUCTION 
The entire pancreatic output of insulin is secreted into the 
portal venous blood which then passes through the liver before reaching 
the systemic circulation. During a single transhepatic passage, 40-50% 
of the insulin is removed (47, 133, 202, 236, 237). Regulation of both 
hepatic and peripheral glucose metabolism is dependent on insulin. 
Therefore, hepatic extraction and degradation of insulin may be impor-
tant determinants in the control of glucose homeostasis. 
Past investigations of the liver's role in insulin regulation 
treated it as a homogeneous organ composed of only parenchymal cells 
(47, 57, 63, 64, 88, 116, 133, 155, 173, 194, 202, 209, 215, 219, 232, 
233, 236, 237, 252, 318, 319, 322, 325, 327, 336, 337, 338, 339, 340, 
361). However, the liver contains several types of cells with the 
following approximate percent distribution: 60.6% parenchymal cells, 
33.4% RES or reticuloendothelial system cells, 2.0% bile duct cells, 
1.8% endothelial cells and 2.0-5.0% connective tissue or fat (vitamin A)-
storing cells (31, 122, 317). Thus, 40% of the cells are non-parenchy-
mal and of these the Kupffer cells of the RES are in the majority, 
making them a numerically significant cell population. 
The Ku~ffer cells are tissue or fixed macrophages which form part 
of the he~atic sinusoidal lining. Because of their location, the 
Kupffer cells are in intimate contact with the pancreatic insulin 
percolating through the liver. Depression of RES endocytic function by 
carbon blockade (36), lead (143, 330) or endotoxin (20, 23, 179, 192, 
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323) has resulted in changes in glucose regulation (52, 55, 56, 79, 84, 
87, 140, 142, 144, 145, 146, 188, 225, 263, 272, 290, 291, 292, 303, 
363, 364). Besides their highly active endocytic processes, the Kupffer 
cells, like all macropi1ages, also carry out numerous metabolic, degra-
dative and secretory functions {7, 8, 73, 113, 127, 210, 239, 240, 264, 
265, 268, 276, 310, 311). Therefore, the Kupffer cells may play a role 
in hepatic insulin regulation. 
The purpose of this study was to investigate the relationship 
between altered RES endocytic function, especially of the hepatic Kupf-
fer cells and insulin regulation. In order to alter RES function, two 
models of RES depression, acute lead treatment (143, 330) and colloidal 
carbon blockade (36), were utilized in male rats. Functional evidence 
regarding the insulin status of the animals was studied by determination 
of the susceptibility to insulin-induced hypoglycemic convulsive death 
and iv glucose tolerance testing. Finally, both basal and glucose-
stimulated serum insulin and glucose levels were measured. 
---
LITERATURE REVIEW 
The Reticuloendothelial System 
Several attempts have been made to classify phagocytic mononuclear 
cells and to define the cell system which they form. During the 1880's, 
Metchnikoff first demonstrated the role of certain phagocytic cells in 
host cellular immunity (24, 158, 276). In his studies, he emphasized 
that ingestion and destruction of foreign bacteria by the "macrophage 
system 11 were essential metazoan disease defense mechanisms (24, 276). 
Later Ribbert and Nagoa and other workers found that intravenously 
injected colloidal dyes or India ink were intensely localized in phago-
cytic cells lining blood sinuses in the liver, spleen and bone marrow 
(7, 196, 244, 276). Subsequently, in 1924, Aschoff introduced the term 
.. reticuloendothelial system 11 (RES) to describe a body of mesenchymal-
derived cells forming a diffuse system of wandering and fixed macropha-
ges having in common the physiological function of rapid ingestion and 
storage of foreign colloidal or particulate matter (7, 276). Aschoff 
included the reticulum and endothelial cells of the lymph nodes, spleen 
and bone marrow, the endothelial cells lining the sinuses in the adrenal 
cortex and anterior pituitary, blood histiocytes or monocytes and con-
nective tissue macrophages (7, 268). Volterra and Thomas proposed the 
name "reticulohistiocyte system 11 , which included all cells that could 
acquire the "histiocytic state" of enhanced metabolic activity, cell 
proliferation and growth, as well as the powers of motility and phagocy-
tosis (158). Their system included bone, muscle, epithelial and Schwann 
3 
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cells in addition to those which Aschoff had placed in the RES (158). 
Unfortunately, true endothelial and reticulum cells are not phago-
cytic rendering the terms RES and reticulohistiocyte system misnomers 
(59). In 1969, a new classification of the monocyte-macrophage system 
was proposed, the 11mononuclear phagocyte system 11 or MPS (59, 158, 159, 
210, 229). Cells were included in the MPS on the basis of similarities 
of morphology, function, origin and kinetics of phagocytosis (158). 
Only 11 professional 11 phagocytes having immunoglobulin and complement 
receptors at the cell surface, the ability to attach to glass and avid 
phagocytic and pinocytic processes were included (158). The MPS cur-
rently is comprised of bone marrow precursor cells, blood monocytes, 
microglial cells of the nervous system and connective tissue, liver, 
lung, lymph node, bone marrow and pleural and peritoneal macrophages 
{159). In this thesis the older name 11 reticu1oendothelial system" is 
used since it is still the most popular, with the understanding that 
only the blood monocytes and macrophages are being discussed. 
Monocyte-r·1acroohage Morpho 1 OCJY 
Mononuclear phagocytes are descendants of hemopoietic stem cells 
(159, 229), not of mesenchymal elements as are the fibroblasts, reticu-
lum and endothelial cells (159). Within the bone marrow, the committed 
stem cell gives rise to the monoblast, which undergoes mitosis and 
differentiates into the promonocyte (158, 159, 210, 229). Promonocytes 
divide to form monocytes which are released into the blood for transpor-
tation to the tissues where further maturation and transformation takes 
place resulting in the formation of the tissue macrophages or histio-
5 
cytes (153, 210,301,321, 345). 
Monocytes leave the circulation and are transformed into macro-
phages via various morphological and functional changes. The circulat-
ing monocyte is a large 10-15 ~m diameter cell with an indented or 
'· 
reniform nucleus having prominent nucleoli, numerous mitochondria and 
lysosomes and a well-developed Golgi apparatus and rough endoplasmic 
reticulum (158, 210). Monocytes can undergo mitosis (320). Like tissue 
macrophages, monocytes phagocytose, adhere to glass and show cytoplasmic 
spreading (210). Locomotion is promoted by undulating cytoplasmic veils 
(210). Immunoglobulin G (IgG) receptors, instrumental in phagocytosis, 
have been found on the cell membrane (320). The half-time of disappear-
ance of monocytes from the circulation has been calculated to be 22 
hours (268). 
After arrival at the tissues, the monocytes become avidly phage-
cytic macrophages having increased numbers of cytoplasmic granules, 
vesicles and lysosomes (268, 320). These cells are larger with reported 
diameters of 10-40 ~m with either an oval or reniform nucleus and in-
creased endoplasmic reticulum (16, 153, 268). Mature tissue macrophages 
infrequently may be stimulated to undergo mitosis~ situ (212, 213, 268, 
358). In chronic inflammatory states, macrophages have been demonstrated 
to have increased lysosomal enzymes and plasma membrane with hypertrophy 
of the Golgi apparatus, all characteristics of "stimulation" or "activa-
tion'' (2, 210). Studies have shown that macrophages have a dynamic mem-
brane system which, as a result of repeated endocytosis, requires re-
plenishment of plasma membrane and synthesis of new primary lysosomes 
(120, 354, 355). Recently Emeis has reported that liver Kupffer cells 
6 
possess a two-layered cell coat composed of an outer filamentous protein 
layer and an inner layer of glycoproteins or glycolipids which may be 
important in endocytosis (121, 123)~ Receptors for both the Fe portion 
of IgG an~ the third component of complement (C3) also have been found 
on the macrophage cell membrane (2.]0, 246, 310). The cytoplasm contains 
a cytoskeletal system of microtubules and also microfilaments, reported 
to be composed of the contractile proteins actin and myosin, which may 
be instrumental for phagocytosis (73, 188, 246,312, 3-13). The life span 
of tissue macrophages is long; it has been estimated to be from 60 days 
to several years (210). 
Endocytosis 
As discussed above, macrophages have been classified as a cell 
system because of their fundamental ability to engulf material from 
their external environment (7, 24, 59, 158, 159, 210, 229, 276). Mono-
nuclear phagocytes are the only cells which exhibit all three types of 
endocytosis: phagocytosis, macropinocytosis and micropinocytosis (159). 
Endocytosis involves an invagination of the plasma membrane with subse-
quent fusion to form vacuoles (174, 242, 266) which may fuse with each 
other prior to transportation to the Golgi or peri-nuclear region where 
they fuse with either primary or pre-existing secondary lysosomes and 
are themselves converted into secondary lysosomes (72, 73, 351). These 
fusions are selective, involving only membrane derived from the plasma-
lemma or Golgi apparatus (73). The molecular mechanisms of membrane 
fusion have not been clarified but defective fusion of vacuoles and 
lysosomes has been shown to occur following ingestion of virulent 
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tubercle bacilli, viable toxoplasma, symbiotic algae (73), polymeric 
dextran sulfate (113) and concanavalin A (73, 110, 111), a lectin (293). 
Failure of degranulation or fusion of primary lysosomes with phagosomes 
also has been reported in human monocytes with the hereditary Chediak-
Higashi syndrome (310). The three types of endocytosis, phagocytosis, 
macropinocytosis and micropinocytosis (2, 210, 240, 268, 275, 313) have 
been shown to involve different sized particles, membrane events and to 
have different metabolic requirements (2, 70, 113, 210, 240, 268, 275, 
310, 311, 313). 
It has been suggested that the term "phagocytosis" should be 
restricted to the uptake of particles~ 1 ~min diameter (2, 210, 313). 
Stossel has divided phagocytosis into 7 events: 1) recognition of the 
particle surface by the phagocyte; 2) the phagocyte receives the message 
of recognition; 3) the phagocyte relays this message to its cytoplasm; 
4) effector mechanisms are aroused which cause the phagocyte to adhere 
to the particle; 5) pseudopods are induced to assemble; 6) and move 
around the particle, and; 7) the tips of pseudopods fuse at the distal 
side of the particle (311). How the macrophage recognizes a particle 
to be phagocytosed is unclear. Several theories have proposed that 
particles are ingested on the basis of molecular properties such as 
surface hydrophobicity, net surface charge or perhaps surface tens ion 
forces (8, 73, 311). In 1903, Wright and Douglas demonstrated that 
normal human serum contained a substance that stimulated bacterial pha-
gocytosis, \vhich they called an "opsonin" (276). Investigators have 
also found opsonic activity in other vertebrate plasma and sera (150, 
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153, 248, 264, 309). Some have considered the opsonins to be specific 
IgG or a fragment of C3 (242, 310, 311) while others have believed that 
opsonins may be "natural antibodies" possibly a-globul-ins (276, 277, 279, 
280, 309): Opsonic activity has been reported to be increased by heparin 
'· 
(147, 148, 149, 150, 264, 276). The binding of the particle, which may 
be opsonized, has been shown to occur at specific receptors, including 
those for the Fe portion of lgG and C3 (210, 246, 310, 311 ). Chemical 
or mechanical events within the membrane have been suggested to transmit 
the receptor binding "message" to the effector mechanism ~vhich causes 
the phagocyte to adhere to the particle to be ingested (311). Stossel 
has proposed that the cell surface contact causes the assembly and 
activation of cytoplasmic actin and myosin, present in microfilaments, 
which may then result in movement of the pseudopods around the particle 
or ingestion (310, 311, 312, 313). The energy needed for phagocytosis 
is provided by the anaerobic glycolytic path\vay with the exception of 
alveolar and hepatic macrophages ~1hich also depend on oxidative metabo-
lism (2, 8, 208, 210, 264, 265). 
"Pinocytosis" refers to the cellular uptake of particles < 1 wn in 
diameter with their fluid medium (210, 268, 313). This process has 
been further divided into "macropinocytosis" which produces vacuoles 
0.3-2.0 ~m in diameter that are visible by phase contrast microscopy and 
"micropinocytosis" \vhich produces 70-100 nm diameter "microvesicles" 
demonstrable only by electron microscopy (2, 210, 240, 268). Pinocytic 
vesicles have been seen to flow centripetally in the cell, apparently 
guided by microtubules (73, 231 ). Pinocytosis is still an obscure 
process and involvement of specific cell membrane receptors has been 
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proposed but not proven (240, 275). Although a single particle can 
trigger phagocytosis, it is now thought that a number of particles must 
accumulate on a given area of cell surface for pinocytosis to occur 
(268). Cohn and Parks have demonstrated that adenosine and ATP as well 
as certain anionic proteins, carbohydra~es, amino acids and nucleic 
acids increase macropinocytosis by mouse macrophages (71, 76, 77, 268). 
Serum has also been shown to induce pinosome formation in mouse macro-
phages (70, 78, 113, 231), particularly newborn calf serum which con-
tains an anti body to mouse ce 11 membranes (2, 71, 72, 78, 113). In-
creased pinocytic activity has been demonstrated to result in increased 
lysosome formation (113). Inhibitors of protein synthesis, glycolysis 
and oxidative phosphorylation have been shown to block macropinocytosis 
(2, 70, 71, 72, 113). Micropinocytosis, on the other hand, has been 
reported to be more resistant to metabolic inhibitors and appears to be 
inhibited by low temperatures when there is less membrane fluidity (2, 
240). Cytochalasin 8, a fungal metabolite which interferes \'Jith micro-
filament function, inhibits phagocytosis (312) and macropinocytosis (2) 
but is ineffective in blocking micropinocytosis (2, 240). It should be 
noted that in the early RES literature, all endocytic acts were commonly 
labeled phagocytosis or phagocytic clearance despite the fact that the 
particles were often < 1 ~m in diameter, as in the case of colloidal 
gold, 30 nm (268, 309) or colloidal carbon 25 nm (36, 180, 309, 359). 
Lewis had discovered pinocytosis in mammalian cells in the 1930's but 
this term was considered to apply only to the cellular uptake of fluid 
with dissolved substances (113). 
RES endocytic activity has been evaluated~ vivo by the intra-
vascular clearance method (20, 21, 36, 179, 276, 309). Various test 
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particles have been utilized including colloidal carbon, colloidal gold, 
saccharated iron oxide, denatured serum albumin, lipid emulsions, latex 
beads, foreign red blood cells, silicon dioxide and chromium phosphate, 
as well as isotopically labeled colloids (20, 21, 36, 37, 179, 276, 309~ 
Benacerraf et ~- have described the characteristics of a good test 
particle preparation as follows: the particles should 1) be phagocy-
tosed by RES cells in contact with the blood, 2) not cross capillary 
walls, 3) be homogeneous in size, 4) stable in the blood, 5) be non-
toxic for the RE cells or the organism, 6) be accurately measurable in 
blood or tissues, and 7) be cleared only by the cells of the RES (21, 
179, 276). Another criterion, added by Saba, is that the functional 
status of theRE cells be the rate-limiting factor, i.e., the avail-
ability of plasma opsonic factors should not be compromised by an 
excessive dose of test material (21, 276, 309). However, Stiffel et al. 
have emphasized that phagocytosis of larger organized particles such as 
bacteria or red cells is dependent on serum opsonin concentration in 
contrast to endocytosis of simple colloids (309). The test dose should 
also be large enough to not be rate-limited by hepatic blood flow (276). 
Kinetics studies have demonstrated that the test particle clearance is 
exponential in nomal circumstances, allovJing the calculation of a half-
time of disappearance (t~) by a semilog plot of concentration versus 
time and the equation k = 0.639/t~ or by the equation K = 0.301/t~ where 
K is the "phagocytic index" and K = k x 0.4343 (20, 21, 36, 179, 276, 
309). It has been demonstrated that 70-96% of a test dose is localized 
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in the hepatic Kupffer cells with most of the remainder found in the 
spleen (36, 179, 276) 309). Similar types of phagocytosis studies mea-
suring the extraction of colloidal carbon, colloidal radiogold, radio-
iodinated albumin aggregates, REtest lipid emulsion and opsonized sheep 
red cells have also been done in vitro in both the isolated perfused rat 
liver and isolated rat Kupffer cells (8, 148, 150, 153, 239, 264, 279). 
The Conceot of RES Blockade 
The classical method for evaluation of the physiological role of 
an organ or system is its surgical removal. Ho~tJever, the diffuse nature 
of the RES made this impossible, so 11 blockade 11 techniques were devised 
in which depression of RES phagocytic function was caused by injection 
of a large dose of foreign particulate matter such as colloidal carbon, 
(12, 20, 21, 22, 36, 38, 103, 179, 205, 213, 243, 259, 309), lead ace-
tate (143, 288) and many other types of colloids, particles and ernul-
sions (12, 20, 21, 38, 90, 179, 212, 243, 278, 309, 343, 359). In vitro 
blockade studies have also been done using foreign blood cells in rat 
and mouse Kupffer cells (239, 301). After the colloidal or particulate 
overload, a state of decreased endocytic activity has been observed for 
a variable period of time which is the blockade state (12, 20, 21, 22, 
36, 38, 103, 143, 179, 205, 213, 248, 259, 276, 278, 301' 309, 359). 
Blockade was then followed by a recovery or even a slight increase in 
phagocytic function (22, 38, 90, 103, 205, 212, 213, 259, 301, 309, 343). 
Several explanations for the phenomena of blockade and recovery 
have been put forth. Classically, blockade was thought to be due to a 
11 physical saturation'' of theRE cells which resulted in reduced cellu-
lar clearance of particles with similar surface characteristics (20, 21, 
12 
36, 179, 243, 247, 309, 359). More recently the idea that the increased 
endocytic activity produces a depletion of opsonins has also been pre-
sented since addition of opsonic substances reversed a state of phugocy-
tic depression (248, 277, 278, 309). Although the depletion of opsonins 
could be ihstrumental in causing RES depression, other investigators 
have reported that the limiting factors for endocytic activity seem to 
be the amount of plasma membrane internalized and the cytoplasmic vol-
ume of the cell, with recovery of endocytosis occurring only after 
synthesis of nev1 membrane (73, 239, 301, 354, 355). Recovery from 
blockade has also been demonstrated to occur by local cellular prolif-
eration and hypertrophy (90, 196, 212, 213, 243) or by replenishment of 
cells from a bone marrow source (301). 
f~onocyte-Nacrophage Substrate t~etabol i srn 
Mononuclear phagocytes have a dynamic intracellular metabolism 
which must provide substrates and energy for both ongoing cellular 
activities and sudden bursts of endocytic activity. The intracellular 
metabolic activity is dependent on several factors including stage of 
cellular maturation, specific tissue location, 11 activation 11 and endocy-
tosis (210). The bone marrow monocyte precursor cells have an active 
glycolytic pathway (210). Maturation into blood monocytes and tissue 
macrophages is accompanied by augmentation of glucose consumption and 
lactate production (210). Hexose monophosphate shunt, aerobic metabol-
ism and cellular respiration are present but less prominent (210, 214). 
With increased development of intracellular organelles, there is an 
increase in protein synthesis and a corresponding elevation of lysosomal 
enzyme activities (210). Specific details regarding macrophage glucose, 
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lipid and amino acid-protein metabolism and their relationship to the 
specific cell type and functional status will be discussed belov1. 
The macrophage possesses an active glucose metabolism which has 
been the subject of numerous studies. Several investigators have re-
ported that both alveolar (165) and peritoneal macrophages (45, 238) 
accumulate glucose by a facilitated diffusion transport system. In 
the alveolar macrophage, this system was inhibited by theophylline and 
was insulin independent (165). This is in contrast to early studies 
on mixed leukocyte populations which reported both an 1!!_ vitro and in 
vivo insulin stimulation of glucose uptake and lactate production (108, 
126). Phagocytosis augmented glucose transport in peritoneal macro-
phages by lowering the ~n value (45). 
Kupffer cells, peritoneal and inflammatory exudate macrophages have 
been shown to contain glycogen stores (131, 175, 176, 269). Interesting-
ly, the wandering macrophage appeared to maintain these stores in two 
ways: 1) via a glycogen synthetase which was found to exist in 2 forms, 
either independent of or dependent on glucose-6-phosphate for activity 
(176) and 2) by uptake of extracellular or exogenous glycogen from incu-
bation media (175, 176), or from glycogen shed from neutrophils into 
exudative fluids (269) or by direct transfer by mononuclear neutrophil 
cellular apposition (269). Although 1!!_ vivo insulin treatment increased 
glycogen synthesis in human leukocytes (126), it had no effect when add-
ed to peritoneal macrophages 1!!_ vitro (174). The glycogen pool of peri-
toneal macrophages 1!!_ yitro \.'/as observed to be very labile and readily 
depleted by incubation in glucose-free media and by phagocytic activity 
(174, 176). T\<'!O glycogen degradative systems are also present in the 
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peritoneal macrophage: 1) a glycogen phosphorylase system and 2) an 
a-1,4 glucosidase of probable lysosomal origin (176). 
Glycolysis seems to be a universal method of energy production in 
mononuclear phagocytes (8, 70, 208, 210, 214, 264); however, the reli-
ance on this pathway may be affected by the microenvironment of the cell 
(210). The alveolar macrophage, which is chronically exposed to high 
oxygen levels, has been demonstrated to utilize oxidative phosphoryla-
tion as its primary energy source in contrast to the peritoneal macro-
phage (208, 210). Several workers have emphasized that both pinocytosis 
and phagocytosis are dependent on glycolysis in monocytes and peritoneal, 
hepatic and alveolar macrophages since they were inhibited by glycolytic 
inhibitors (2, 8, 70, 208, 210, 264). During phagocytosis, peritoneal 
macrophages have also demonstrated great increases in Krebs cycle activi-
ty and smaller increases in hexose monophosphate shunt activity (2, 208). 
Alveolar and hepatic macrophages which normally utilize oxidation of 
glucose and the hexose monophosphate pathway (8, 210, 264, 265, 268) 
did not show such a marked elevation in oxidative metabolism during 
phagocytosis (8, 208, 210, 264, 265, 268). Glucose oxidation in iso-
lated Kupffer cells has also been found to be non-responsive to~·vitro 
addition of insulin (264). ''Activation 11 is a phenomenon ~·Jhich results 
in increased cell size and enhanced macrophage phagocytic digestive and 
microbicidal activity (210). Activated or 11 elicited 11 macrophages have 
been found to possess increased size and number of lysosomes, elevation 
in acid hydrolases, an enlarged Golgi zone and increased plasma membrane 
ruffling as well as an increased glucose oxidation (208, 210). Activa-
tion has been induced by exposure to various agents which include 
caseinate (208) thioglycollate, bacterial lipopolysaccharide, immune 
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complexes and facultative intracellular bacteria (210). 
In addition to their continuous utilization of glucose, macro-
phages also carry on a dynamic lipid metabolism. This area of investi-
gation ha~ been divided into 3 research topics: 1) cellular synthesis 
and oxidation of fatty acids and triglyceride synthesis and degradation, 
2) the relationship between macrophages and atherosclerosis including 
cholesterol and lipoprotein metabolism and 3) the tremendous lipid turn-
over of the cell membrane following endocytosis. Two studies by Pisano 
et ~- demonstrated that isolated rat Kupffer cells oxidize exogenous 
acetate to co2 (264, 265) and that this oxidation decreased during phago-
cytosis (265), suggesting that marcophages might possess a significant 
fatty acid metabolism. Both hepatic and peritoneal macrophages have 
been shown to oxidize l- 14c-palmitate (91, 264). Rabbit peritoneal and 
alveolar macrophages also oxidized 14c-labeled triglycerides (91, 118) 
implying the existence of a lipolytic system. Elsbach found a high 
lipase activity in rabbit alveolar macrophages and obtained evidence 
that lipolysis preceded uptake of glycerides which were then esterified 
in the cell (118). Other histochemical and biochemical studies have 
indicated that macrophages possess both cytoplasmic esterase and lipase 
activity (92). Alveolar macrophages also incorporated free fatty acids 
complexed to albumin or in chylomicrons into cellular lipids; this in-
corporation was suppressed by the addition of glycolytic inhibitors 
(118). Macrophages have also been shown to synthesis fatty acids and 
mono-, di- and triglycerides from acetate (93, 210). Recently, Wagle 
et al. have reported that epinephrine, but not glucagon, stimulated 
---
lipolysis of triolein and tripalmitin by isolated rat Kupffer cells (34~. 
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A nunber of early observations implicated a role for the RES in the 
uptake of triglycerides, cholesterol, phospholipids and lipoproteins. 
Many of those experiments were done using artificial triglyceride emul-
sions whic~ ~\lere readily ingested by Kupffer and other RE cells and 
suggested, therefor~ that the Ku~ffer cells might remove lipid from the 
circulation and transfer it to the liver parenchymal cells (92, 304). 
However, as mentioned above, macrophages do metabolize the lipid they 
take up (91, 92, 118). Additionally it was found that Kupffer cells 
handled artificial emulsions differently than biological lipoproteins 
(92), possibly because the emulsions were recognized as foreign and 
because lipids from chylomicrons ~vere taken up directly by the paren-
chymal cells (92). 
Cholesterol, a component of lipoproteins, has been shown to accumu-
late in RE cells after oral, ip or iv administration (1, 33, 92, 94, 
107) and in Tangier Disease, a genetic deficiency of heavy-density lipo-
protein or HDL (195). Macrophages also internalized cholesterol from 
in vitro incubation media (33, 91, 92, 355). Despite one isolated report 
of macrophage synthesis of cholesterol from acetate (93), it is generally 
thought that macrophages do not synthesize it and rely on the external 
medium as their sole source of cholesterol (210, 354, 355). Rabbit 
peritoneal macrophages could not oxidize cholesterol (91 ), supporting 
other studies which demonstrated active macrophage cholesterol esterifi-
cation (92, 93, 94, 95). Normally cholesterol esters are not further 
metabolized, but are stored in the cell (83, 92, 94, 195) and excluded 
from incorporation into cellular membranes (83). A recent study by 
Drevon ~ ~-, however identified the presence of a lysosomal cholesterol 
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esterase in hepatic macrophages which hydrolyzed cholesterol esters 
contained in HDL (106) . .II!_ vivo, cholesterol, free or esterified, is 
normally transported within plasma lipoproteins because sterols are 
virtually insoluble in aqueous media (83). It has been hypothesized 
that free cholesterol is then incorporated into cell membranes by 
exchange diffusion from the lipoproteins (83). Once in the cell, the 
free cholesterol equilibrates between the plasma and organelle membranes 
(83). There may also be an endocytic uptake of lipoproteins by macro-
phages as has been implicated in fibroblasts and other cells (48, 49). 
Brown and Goldstein have proposed that low-density lipoproteins (LDL) 
first bind to a cell surface receptor, leading to endocytosis of the LDL 
with lysosomal protease hydrolysis of the protein component to amino 
acids, released from the cell, and hydrolysis of the cholesterol ester 
component by a lysosomal lipase, with the resulting unesterified chole-
sterol being incorporated into cell membranes (48, 49). They have also 
suggested that the level of LDL presented to the cell has a negative 
regulatory influence on the synthesis of LDL receptors (48, 49). Kupffer 
cells have been suggested to be a site of LDL catabolism (245); uptake of 
HDL has been demonstrated in hepatic macrophages (106). Concanavalin A 
inhibited cholesterol ester uptake by hepatic nonparenchymal cells, 
suggesting the presence of a carbohydrate-containing lipoorotein binding 
site ( l 06). 
Knowing about the macrophage's propensity for lipid uptake, it 
should be no surprise that many investigators found lipid-laden macro-
phages or "foam cells" at the sites of atherosclerotic plaque formation 
(1, 82, 92, 107, 183). Histological studies verified that these foam 
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cells were of two types, lipid-containing macrophages and smooth muscle 
cells, in the intimal layer of arterial blood vessels (1 ~ 82, 92, 107, 
183). Adams et ~.,demonstrated the sclerosing effect of cholesterol 
on connective tissue and that phospholipid promoted macrophage uptake 
of cholesterol (1). They interpreted this as evidence of a protective 
role of macrophages in removing tissue-irritating cholesterol aggregates 
(1). As was mentioned above, macrophages tended to accumulate chole-
sterol esters (91, 92, 94, 106) which seemed in turn to promote deposi-
tion of other plasma or newly synthesized lipids in macrophages lining 
the arterial wall (92). These cells are then taught to die, leaving a 
sequestered pool of interstitial lipids, forming the gruel-like core of 
the plaque (82, 183). When exposed to an increased cholesterol-phos-
pholipid ratio, such as occurs with ingestion of a cholesterol-rich, 
atherogenic diet, mammalian cells tend to accumulate cholesterol in 
their membranes (83). Cooper has hypothesized that the formation and 
storage of cholesterol esters occurring in atherosclerosis may be an 
adaptive process designed to divert the cholesterol to a form excluded 
from cell membrane structure, preventing deleterious changes in fluidity 
(83). In fact a decrease in membrane fluidity due to an increase in the 
membrane ratio of cholesterol to phospholipid content has been associated 
with a decreased endocytic ability in macrophages (83). 
During a bout of endocytic activity, a macrophage may internalize 
50-60% of its plasma membrane (73, 354), resulting in an increased lipid 
turnover (268). Surface lgG receptors and 5'-nucleotidase present on 
the plasma membrane also have been found to disappear after phagocytosis 
(239, 285, 354, 355). After such maximal endocytosis, cells rounded up 
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and ceased both pinocytic and phagocytic activity for 5-6 hours (73, 
355). Over this period of time, biochemical changes suggesting syn-
thesis of new membrane occurred including increased RNA, protein and 
phospholip~d synthesis and a net increase in membrane RNA, protein and 
phospholipid synthesis and a net increase in membrane cholesterol (73, 
119, 120, 210, 354, 355). Plasma membrane synthesis required the pre-
sence of exogenous cholesterol and was blocked by inhibition of protein 
and RNA synthesis (354, 355). The increased membrane synthesis does 
not occur at the site of vacuole formation but is only evident 6 hours 
after endocytosis (210, 354). Macrophages have been shown to synthesize 
phospholipids from labeled acetate (93), choline (354) and lysolecithin 
(120). Phospholipids containing labeled choline have been localized in 
plasma membrane and secondary lysosomes; they have also been shown to be 
exchanged between cytomembranes via a specific cytosolic protein (210, 
354). The amount of new membrane synthesized has been reported to be 
linearly related to the amount of membrane initially internalized (73) 
with quantitative restoration of its original composition (354). 
After formation of an endocytic vacuole, there is fusion of the 
membrane resulting in a pinosome or phagosome lined with the plasma 
membrane constituents which were originally on the exterior of the cell 
(73). Subsequent fusion of the vacuole with lysosomes leads to discharge 
of acid hydrolases and digestion of endocytized macromolecules, including 
membrane polypeptides, to small molecular weight products (73, 113). 
Thus plasma membrane molecules such as 5'-nucleotidase, phosphodiesterase 
and IgG receptors have been observed to disappear following endocytosis, 
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only to be replaced later (73, 239, 285, 354, 355). Macrophages are 
capable of nucleic acid synthesis, both RNA and DNA, (210, 212, 213, 
268) and possess a well-developed endoplasmic reticulum for protein 
synthesis (210, 268). The replacement of membrane components has been 
shown to occur after RNA and protein synthesis (73, 354, 355). Indue-
tion of lysosomal enzymes and increased formation of lysosomes has also 
been noted in response to endocytic activity (113, 354). Cohn ~t ~-· 
followed the intracellular flow of 1eucine-H3 in mouse peritoneal macro-
phages (75). They found that there is initial labeling of the rough 
endoplasmic reticulum, followed by appearance of the label in the Golgi 
complex and finally the dense granules contained the majority of the 
isotope and suggested that lysosomal hydrolytic encymes are synthesized 
in the endoplasmic reticulum and then transferred to the Golgi apparatus 
where the enzymes are packaged into small Golgi vesicles resulting ih 
formation of primary lysosomes (75). 
Alveolar macrophages have been shown to possess carrier-mediated 
transport systems for adenosine and lysine (30, 332, 354). These trans-
port sites were apparently preserved after 35-50% of the membrane was 
internalized since constancy of transport activity did not depend on 
production of new transport sites (332). A role for microtubules in 
maintaining a separation of the transport and phagocytic sites has been 
suggested (30, 246, 332, 354). This preservation of amino acid and 
nucleotide transport during endocytosis seems appropriate for the 
succeeding bout of protein synthesis. However, a recent report present-
ed evidence that protein synthesis and leucine transport were inhibited 
in suspended alveolar macrophages after repeated \'lashing, perhaps by the 
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removal of a necessary surface membrane RNA (334). 
Besides synthesizing proteins to maintain their cellular integrity, 
macrophages synthesize and secrete many other proteins. Macrophages, as 
discussed previously, actively synthesize lysosomal enzymes which have 
been reported to be released outside the cell during endocytosis (2, 73, 
89, 96, 127, 210, 224, 230, 299, 310,352). Only about 10-15% of the 
total cellular lysosomal acid hydrolase activity appeared extracellularly 
(73). In contrast, 85-90% of the enzyme lysozyme was secreted indepen-
dent of cellular activity (73, 127) and may be a major macrophage secre-
tory product (73). Another enzyme, plasminogen activator, which is 
involved in lysis of fibrin and cleavage of complement proteins and 
Hageman factor via conversion of plasminogen to plasmin, was secreted 
primarily by activated macrophages (73, 127). Synthesis of collagenase 
and elastase for export has been observed (127, 230, 349). Macrophages 
have been shown to synthesize serum complement proteins Clq, C2, C3, C4, 
and C5 (71, 115, 127, 210, 230, 305, 306) as well as transferrin (125, 
210, 305, 306). Production of a variety of proteins related to immuno-
logical functions by macrophages such as colony-stimulating factor, in-
terferon and lytic, stimulatory or inhibitory factors has also been 
demonstrated (89, 127, 210, 230, 249, 275, 320). After phagocytosis, 
macrophages, especially Kupffer cells have been reported to produce the 
protein endogenous pyrogen (9, 19, 42, 43, 102, 127, 171, 178, 210, 351) 
which may or may not be related to leukocytic endogenous mediator, a 
protein synthesized and released by macrophages and blood leukocytes (19, 
206, 260). Two recent reports have even implicated macrophages in regu-
lation of the renin-angiotensin system by production of angiotensin-
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converting enzyme (156, 222). Thus, the secretory function of macro-
phages gives the RES the potential to exert a regulatory influence on 
its environment within the organism and to function almost as an endo-
crine organ. 
Metabolic Role of the RES in the Organism 
Aschoff in his studies on the RES was obviously aware of the impor-
tant role of macrophage metabolism in the organism when he proposed the 
name 11 histiocytic metabolic apparatus 11 as an alternate title for the RES 
(7). The macrophages have been implicated in many catabolic and trans-
formation reactions such as drug metabolism and detoxification (100, 276) 
and, as discussed above, in lipoprotein and cholesterol transformation 
and metabolism (1, 7, 20, 33, 91, 92, 93, 94, 95,106,107, 118, 245, 276, 
354, 355). Berliner demonstrated that adrenal cortical RE cells are 
involved in cortisol production from progesterone while the hepatic RE 
cells clear steroids and cause steroid ring A reduction preparatory to 
excretion (31, 32). Thyroxine degradation during bacterial phagocytosis 
has also been reported (98). A relationship between RE cell activity and 
transcobalamin II metabolism has been suggested (167). Macrophages seem 
to regulate the clotting system by several routes since they produce 
plasminogen activator (73, 127) and have been demonstrated to clear both 
fibrin aggregates (220) and thromboplastin (302). 
Some of the earliest known RES functions were the sequestration and 
destruction of aged, foreign or damaged red blood cells and circulating 
hemoglobin with subsequent bile pigment or bilirubin formation and con-
servation of the heme iron in ferritin (7, 20, 72, 125, 159, 160, 239, 
268, 276). The globin moiety of hemoglobin is degraded by proteases and 
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the heme by heme oxygenase (320). Iron stored as ferritin is trans-
ported back to erythroid precursors via the protein transferrin, secreted 
by the macrophage (102, 125, 210, 306). Transferrin molecules have been 
proposed to,_ deliver the iron to the cell surface of the erythroid pre-
cursors and return empty to theRE cells to pick up another load (125, 
320). Others have suggested that macrophages in the bone marrow serve 
as 11 nurse 11 cells in an island of developing cells, supplying iron by 
transferrin or by direct ce11-to-ce11 delivery (125, 320). 
RE cells are very active in removal and degradation of effete, 
autologous tissue, antigens and proteins by means of their extensive 
array of lysosomal enzymes {2, 25, 74, 89, 111, 113, 210, 224, 241, 276, 
352). Macrophages have been shown to arrive at the site of inflammation 
later than polymorphonulcear leukocytes (89, 137, 224). The macrophages 
appear to function as 11 Scavenger 11 cells, phagocytizing fibrin and cellu-
lar debris in preparation for repair (224). Several in vitro studies 
have demonstrated macrophage segregation and digestion of radiolabeled 
serum albumin, bovine gamma globulin, hemoglobin, horse radish peroxi-
dase and polypeptides in secondary lysosomes (20, 71, 72, 111, 112, 113). 
Apparently the macrophages digested the proteins down to the level of 
amino acids (71, 72, 113). Chronic inflammatory conditions can be per-
petuated by macrophage release of lysosomal enzymes, collagenase, elast-
ase, cytotoxic activities, prostaglandin release and activation of o~teo-
clasts (127, 168, 224, 230, 349, 351, 352). Macrophages may also help 
in elimination of unwanted protein by secreting proteolytic enzymes 
during absorption of the tadpole tail during metamorphosis and the period 
of collagen resorption in the post-partum uterus (96, 127). Experi-
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mental absence of macrophages led to an increased amount of fibrin 
debris and a slowing of fibrinogenesis in wounds (127). Rebuck et ~., 
also discussed the phenomenon of leukocytic glycogen transfer to macro-
phages at tcnflammatory sites (269). Both Cohn (74) and Gudewicz (175, 
176) found that macrophages possess enzymes of probable lysosomal origin 
capable of hydrolyzing a-lined polysaccharides. Macrophage a-1,4 glu-
cosidase activity may provide an additional source of glucose via endo-
cytosed glycogen not only to the inflammatory macrophage but to other 
cells at the site since a portion of this glucose is released to the 
outside (175, 176). 
The cells of the RES tend to accumulate phagocytizable organic 
material when it is present in the body in amounts that cannot be rapid-
ly disposed of by normal catabolic or excretory processes such as in 
storage diseases or conditions with excessive cell turnover and death 
(74, 96, 159, 320, 351). Hemosiderosis, asbestosis, silicosis and xan-
thomas are examples of storage diseases caused by macrophage endocytosis 
of nondigestible materials (159). Inborn genetic enzyme deficiencies 
can result in macrophage lysosomal enzyme deficiency storage diseases 
characterized by the presence of undigested material in the lysosomes 
(74, 159, 320, 351). Cohn was able to induce a similar disorder in vitro 
by allowing mouse peritoneal macrophages to pinocytose sucrose or Ficoll, 
a polysucrose (74). Interestingly, antigenic substances, for example, 
a-globulins and keyhole limpet hemocyanin, may bypass extensive catabol-
ism by either remaining bound to the plasma membrane or undergoing only 
partial degradation and processing for release from the cell to stimulate 
lymphocyte function (85, 210). 
25 
Since the time of Metchnikoff, the role played by the RES in host 
cellular immunity by clearance of potentially harmful bacteria and 
viruses from the body has been emphasized (14, 20, 38, 58, 89, 179, 196, 
263, 276, 487). The RES has also been considered to be instrumental in 
the clearance of endotoxin, the lipopolysaccharide component of gram 
negative bacterial cell walls having a molecular weight of about 1 mil-
lion, normally preventing a fatal shock episode (18, 20, 23, 41, 44, 53, 
101, 129, 171, 179, 192, 196, 274, 276, 323, 350, 353, 370). Bona found 
that macrophages appeared to take up endotoxin by pinocytosis (44). 
Macrophages have been shown to detoxify endotoxin via lysosomal activity 
or perhaps by elaboration of a blood antiendotoxin system (135, 136, 137, 
138, 139, 141, 329, 353). It has long been known that the acute admini-
stration of endotoxin to an animal results in depression of RES function 
(20, 23, 179, 192, 323). This RES depression may be the result of the 
profound alterations in glucose metabolism caused by endotoxemia (52, 
54, 55, 56, 79, 87' 134, 140, 145, 146, 188, 225, 263, 272, 290, 291, 
292, 303, 363, 364). 
RES - Hormone Interactions 
In prior sections of this review, several instances of RES interac-
tion with various segments of the endocrine system were mentioned. 
Although the RES does participate in the metabolism and synthesis of 
hormones and in turn RES functions are affected by certain hormones, the 
elucidation of this area of RES physiology has only begun. Some of the 
earliest observations concerned the effects of estrogens on the endocytic 
function of the RES. It is generally believed that the female mammal is 
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more resistant to stress than the male. This belief has not been 
systematically investigated; however, it has been suggested that the 
female hormones, especially the estrogens, may stimulate RES function 
and thus increase cellular immunity (4). In 1935, Nicol found that 
' 
estrogenic hormones seemed to induce the formation and stimulate the 
activity of guinea pig uterine macrophages (316). Several investigators 
reported that phagocytic activity increased during the two peak levels 
of estrogen present during the human menstrual cycle and in the estrous 
cycle of lower mammals (316, 342). Ovariectomized rodents showed 
decreased phagocytic activity with a decline in the number of uterine 
macrophages (342). Estrogen replacement increased the number of macro-
phages in spayed animals (342). During the early implantation and late 
stages of pregnancy, RES endocytic activity is elevated (316, 342). 
Ovariectomy reduced survival against highly virulent infections (342). 
In the rat, females were reported to have greater ability to clear 
colloidal carbon and greater resistance to lethal circulatory trauma (4). 
In male rats, estrogen treatment conferred trauma resistance and caused 
hyperactivity of the RES (4). Thus, in general, estrogenic steroids have 
an unequivocal st-imulatory effect on RES endocytic activity (4, 179, 316, 
342). Several mechanisms for this stimulation have been presented 
including an increased migration of mononuclear cells from the bone 
marrow (331, 342), local cellular proliferation, especially in the liver 
(342), higher phagocytic activity of the available macrophages (342) and 
an elevated rate of energy metabolism, especially of hexose monophosphate 
shunt activity (214, 342). 
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Another group of steroids, the adrenal corticosteroids also have 
profound effects on the RES. Patients with Cushing's syndrome, charac-
terized by an excess of corticosteroids or with Addison's disease and a 
lack of corticosteroids both showed increased susceptibility to infection 
{316). Pharmacological doses of cortisone also were known to reduce the 
resistance of man and animals to bacteria, viruses, fungi and bacterial 
toxins (22, 38, 316, 342). Therefore, experiments were done to determine 
the reasons for the impairment of immunity, particularly of the phagocy-
tic function of the macrophages. Heller reported that cortisone admini-
stration depressed RES colloid clearance in both rats and mice (186, 
316). Others reported no effect of cortisone on the basic RES endocytic 
activity (21, 22). Cortisone administration did delay the recovery phase 
following colloidal blockade (22, 179, 316) and suppressed the normal 
stimulatory reaction of the RES to bacterial products (38). Insight into 
the mechanism by which corticosteroids influence RES kinetics was pro-
vided by studies on inflammation (130, 324). In normal mice, subcutane-
ous injection of corticosteroids resulted in a rapid drop in the number 
of blood monocytes released from the bone marrow (324) and inhibition 
of macrophage accumulation in sites of inflammation (130). It is likely 
then that corticosteroids do not modify the phagocytic properties of 
macrophages ~ ~ (130). In contrast to the above findings, smaller 
doses of cortisone reportedly stimulated RES phagocytic activity (316, 
342). This is consistent with the report that cultured peritoneal macro-
phages required cortisol in the culture medium to maintain normal func-
tions such as serum protein synthesis (156, 306). Altura has also found 
that glucocorticoids prevented the early RES depression seen in circula-
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torY shock (3). Yet the same small doses of cortisone which enhanced 
RES endocytic activity inhibited macrophage digestive and bactericidal 
capacities (130, 342). This last effect may be the result of cortico-
steroid inhibition of degranulation (130, 310) and stabilization of 
lysosomes (224, 351). It is now accepted that small doses of cortico-
steroids maintain or enhance RES function while large doses depress it 
(99, 342). It should be reiterated that adrenal cortical macrophages 
produce cortisol from progesterone while hepatic Kupffer cells clear 
steroids and cause ring A reduction preparatory to conjugation and 
excretion (31, 32). Thus macrophages also have a role in regulation of 
steroids which in turn influence their activity. 
Because of the known interactions of the RES and adrenal cortico-
steroids, studies were done to ascertain the effects of hypophysectomy 
on RES function (35, 99, 211). DiCarlo et ~- found that hypophysectomy 
did not affect the rate of phagocytosis in mice (99). However, others 
found that long term effects of this operation included a progressive 
fall in RES phagocytic capacity (35, 211) possibly due to a decrease in 
RES mass and blood volume (211). Although Keefe et~. found that zyrno-
san-induced stimulation was still possible after pituitary removal in 
rats (211 ), DiCarlo et ~- could not cause RES stimulation in hypophy-
sectomized mice unless they were treated with ACTH (adrenocorticotropin), 
pituitary suspension or corticosterone (99). The latter group hypothe-
sized that ACTH may be stimulatory to the RES via increased adrenal cor-
tical secretion (99). 
Bilder noted both thyroidectomy and hypophysectomy decreased the 
RES maximum phagocytic rate or V111 (35). She attributed this effect to .ax 
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the resulting decrease in thyroid hormone since thyroxine treatment 
restored Vmax to intact levels (35). The thyroid hormones may maintain 
RES function by regulating v1hole body metabolism (35) rather than by a 
direct effect, as proposed by Stambul (204). Recently DeRubertis and 
~Joeber demonstrated the uptake and metabolism of thyroxine by hepatic 
macrophages during Samonella tyohimurium sepsis in monkeys (98). They 
proposed that thyroxine could influence the host phagocytic cell func-
tion (98). 
In addition to metabolizing hormones or being affected by them, ma-
crophages also produce hormone-like substances which influence the secre-
tion of endocrine glands. Besides adrenal cortical macrophage participa-
tion in glucocorticosteroid production (32), macrophages have been shown 
to release large quantities of prostaglandins (168, 230). Rabbit alveo-
lar macrophages, exposed to physiological concentrations of corticoste-
roids, contained increased levels of angiotensin converting enzyme (15~, 
suggesting that the RES may influence the regulation of blood pressure. 
In macrophage related diseases, such as Gaucher's disease, increased ma-
crophage production of serum angiotensin converting enzyme has also been 
observed 056, 222). After l.!!_ vivo stirilulation with bacteria, macrophages 
have been shown to produce leukocytic endogenous mediator, a protein pro-
duced by leukocytes, which causes a shift of amino acids from muscle to 
liver, increased hepatic amino acid uptake, cAMP levels and glycogenoly-
sis as well as elevation of plasma insulin and glucagon levels with host 
hypoglycemia 0 9, 166, 206, 260). Therefore, the macrophages may regulate f)an-
creatic insulin and glucagon levels and the host's metabolic responses 
to infection (166). Moore et al. have likewise demonstrated that macro-
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phages exposed to endotoxin produced an anti-gluconeogenic substance 
which inhibited corticosteroid induction of phosphenolpyruvate carboxy-
kinase (235), an insulin-like effect. 
Classically the effects of hormones affecting hepatic metabolism 
were thought to occur only at the parenchymal cells. This generalization 
is no longer valid since the identification of a hormone sensitive adeny-
late cyclase in Kupffer cells (270, 347, 348, 362). Despite one report 
of glucagon-sensitive adenyl cyclase being located in the RE cells (270), 
studies on isolated cells demonstrated that epinephrine sensitive adeny-
late cyclase predominated (347, 348, 362). Wincek and coworkers found 
that Kupffer cell adenylate cyclase was stimulated by fluoride ion, GTP 
and catecholamines as monitored by cAMP production (362). Wagle et ~­
demonstrated that epinephrine, but not glucagon, stimulated hepatic 
macrophage lipolysis (348). The latter group also claimed that both 
epinephrine and, to a lesser extent glucagon stimulated gluconeogenesis 
in Kupffer cells (347, 348); however, these results could be due to 
parenchymal cell contamination. 
Because Kupffer cells are responsive to catecholamines and glucagon, 
and by inference possess "receptor sites" for these hormones, it seems 
reasonable to investigate the effect of insulin on Kupffer and other RE 
cells. Initially, the increased susceptibility to infection seen in 
diabetics (10) sparked interest in this topic. Several immunodeficien-
cies have been identified in human diabetics including decreased or 
missing antibody formation to bacterial antigens (223), possibly due to 
inhibition of lymphocyte blastogenesis, as was reported in diabetic rats 
(256), decreased numbers of peripheral T-lymphocytes (60) and impaired 
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leukocyte migration (161). Several workers also noted depressed phago-
cytosis by granulocytes and macrophages in the diabetic state (10, ll, 
105, 269). Yet Berken and Sherman found that RES phagocytosis was 
normal in diabetes (27) and Gabrieli and associates found it to be 
abnormally accelerated (161). The discrepancies in these results have 
been explained by the direct correlation between successful blood glu-
cose management with insulin and the return to normal phagocytic func-
tion (10, 11, 27). Apparently the elevated blood glucose levels and 
hypertonicity depressed phagocytosis (67, 105, 283, 310). Rebuck et a 1 . 
using his 11 skin window 11 technique demonstrated that diabetics did show a 
defective inflammatory response which he attributed to a failure of 
leukocytic glycogen transfer to mononuclear phagocytes (269). Neutro-
phils from severely diabetic patients, in that study, showed abnormally 
high glycogen concentrations accompanied by decreased neutrophil migra-
tion and phagocytosis in contrast to cells from well-controlled diabetics 
and controls which shed their glycogen to lymphocytes, monocytes and 
macrophages (269). 
Still other investigators sought to further characterize the effect 
of insulin directly on white blood cells and macrophages. Dumm studied 
the effect of insulin on glucose utilization by mixed white blood cells 
and reported increases in cells from both normal and diabetic subjects 
after both~ vivo insulin administration and~ vitro using 0.1-0.5 U/ml 
of insulin (108). Esmann, also saw a slight in vitro insulin effect on 
glucose uptake by human leukocytes with l U/ml and a 4 hour incubation; 
no effect was observed on glycogen synthesis (126). Studies specifically 
on macrophage glucose metabolism yielded similar results since insulin 
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had no effect on glucose transport in alveolar macrophages (165) or on 
peritoneal macrophage glycogen synthesis (174). Kupffer cell glucose 
oxidation was also unaffected by insulin (264). Generally speaking, 
insulin seemed to have no effect on macrophage glucose metabolism. 
The apparent leukocyte insensitivity to insulin puzzled investiga-
tors since mixed leukocytes had been reported to bind large amounts of 
insulin compared to other tissues (184) and binding was similar in normal 
and diabetic cells (296). Gavin, Archer and their coworkers subsequently 
demonstrated that circulating and cultured B-lymphocytes contained speci-
fic insulin binding sites (163, 164). However, a study by Krug et ~· 
detected no such receptors on resting lymphocytes; it is very likely that 
they had a T-lymphocyte cell population (217). Insulin receptors appear-
ed to be present on the T-cell only after~ vitro transformation with 
concanavalin A (217) or after immune activation (185, 315). Insulin 
caused an augmentation ofT-lymphocyte cytotoxicity (185, 315) and in 
another study, it increased both glucose transport and membrane ATPase 
activity in human lymphocytes (177). Thus insulin binding had functional 
consequences in lymphocytes. Gavin and coworkers also reported that 
chronic (5-16 hr) exposure of cultured human lymphocytes to insulin re-
sulted in a reduction of insulin receptor concentrations, suggesting a 
reciprocal relationship between the amount of insulin in extracellular 
fluid and the number of insulin receptors per cell which directly affects 
target-cell hormone sensitivity (164). Lymphocytes were then utilized 
in several studies for investigation of possible insulin receptor binding 
defects to explain the conditions of insulin resistance (5), diabetes 
(253) and obesity (6). 
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In a study on insulin receptors on human mononuclear leukocytes, 
Swartz and associates demonstrated that although lymphocytes constituted 
80% of these cells, the amount of 1 2 5I-labeled insulin specifically 
bound corr~lated significantly only with the number of monocytes (286). 
Autoradiograms of blood smears also showed that only monocytes bound the 
labeled insulin (286). .l\pparently many of the experimenta 1 11 lymphocyte 11 
preparations were contaminated with monocytes and thus showed insulin 
binding and likewise no binding if measures were taken to insure deple-
tion of monocytes (185). Monocytes were then immediately used to further 
investigate the disorders of obesity (251) and diabetes (254, 255). 
Diabetes mellitus and obesity were both accompanied by decreases in in-
sulin receptor number (250, 254). The use of circulating monocytes was 
instrumental in ident-ifying a cause for the diabetic syndrome of acan-
thosis nigricans in which patients show a marked resistance to insulin 
probably due to the presence of insulin receptor antibodies (154, 203, 
204) or a decrease in binding affinity (204). Recently, Thorsson and 
Hintz reported that monocytes also possess specific receptor sites for 
the insulin-like substance somatomedin (325). 
Since the discovery of monocyte insulin receptor binding, investi-
gators have endeavored to find some associated biological functions in 
RES cells. One of the earliest observations on a possible effect of 
insulin was in a study by Stossel ~! ~- on phagocytosis (314). Although 
that study utilized polymorphonuclear leukocytes, it is significant to 
note that~ ~itro addition of insulin at a physiological concentration 
of 2 mU/ml slightly stimulated the phagocytic rate (314). In a later 
report, Rhodes demonstrated that guinea pig peritoneal macrophage Fe 
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receptor expression is modulated by insulin and cyclic nucleotides (271). 
In both human monocytes and mouse spleen macrophages, insulin inhibited 
antibody-dependent cytotoxicity (13) possibly by decreasing the number 
of Fe receptors (271). Therefore, macrophages appear to possess func-
tionally significant specific insulin receptors. Several groups, work-
ing independently, demonstrated that peripherally injected l31I or 1 2 5I-
insulin tended to be localized in hepatic Kupffer cells (17, 307, 366), 
as did injected insulin-antibody complexes (157). Chandler and Varandani, 
working with a mixed blood leukocyte population, have identified the 
insulin-degrading activity present as the enzyme glutathione-insulin 
transhydrogenase (65). Additionally, both glutathione-insulin transhy-
drogenase and insulin specific protease were found in the lysosomal 
fraction of rat liver (173). Because Kupffer cells are rich in lysosomes 
and lysosomal enzymes (25, 241, 299) and are in intimate contact with 
pancreatic insulin secreted into the hepatic portal circulation and 
possess active secretory, metabolic and degradative processes, it is 
possible that Kupffer cells may participate in the modulation of insulin 
activity in the organism. 
The Effect of RES Depression on Glucoregulation and Shock S~sceptibility. 
Since it was known that the RES played a significant role in the 
removal of pathogenic organisms and endotoxin, which if left unchecked 
could produce a shock type of death, studies were conducted to determine 
if blockade of the RES by other substances could increase shock suscep-
tibility. Depression of the RES by saccharated iron oxide, thorotrast, 
large doses of cortisone or whole body irradiation increased the inci-
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dence of death from traumatic or endotoxin shock (142, 152, 227, 369). 
Similarly lead acetate treatment also sensitized rats to death by endo-
toxin shock (79, 80, 81, 135, 143, 288, 329). Interestingly, stimula-
tion of RE.S function by zymosan, endotoxin, estrogens or induction of 
trauma resistance decreased susceptibility to shock death (4, 151, 192, 
369' 371). 
RES depression by colloidal carbon blockade has also been demon-
strated to cause alterations in glucose regulation as judged by 1) the 
enhanced hypoglycemic response to insulin, 2) increased insulin-induced 
hypoglycemic lethality, 3) decreased gluconeogenesis and 4) increased 
total body glucose oxidation (142, 144). Lead administration has also 
been shown to cause decreased gluconeogenesis and increased hypoglycemic 
response to insulin (52, 84, 140). Endotoxemia and gram negative sep-
sis also depress the RES (20, 23, 179, 192, 323) producing similar but 
more profound changes in glucose homeostasis along with changes in in-
sulin activity (26, 55, 56, 79, 86, 87, 142, 145, 146, 172, 188, 189, 
225, 263, 272, 290, 291, 292, 303, 363, 364) suggesting that the RES 
governs the host metabolic response to endotoxin not only by clearance 
of bacteria and endotoxin but by modulating insulin levels. Considera-
tion of the above date indicates a probable relationship between RES 
functionaf status and insulin regulation. 
Statement of Purpose 
-------------
The purpose of this study was to investigate the relationship between 
altered RES endocytic function and insulin regulation. In specific, 
experiments were performed: 
1. to investigate the effect of RES depression, using acute lead 
acetate administration, on susceptibility to insulin-induced hypoglycemic 
convulsive death; 
2. to evaluate the influence of RES depression on iv glucose toler-
ance and; 
3. to ascertain the effect of RES depression by either colloidal 
carbon blockade or acute lead treatment on actual basal and glucose-
stimulated serum insulin levels as measured by the Phadebas radioimmuno-
assay. 
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METHODS 
A. Animals 
Ad~lt male albino Holtzman rats (Madison, Wisconsin) were used in 
all experiments. The rats were housed 3-5 per cage and allowed to 
acclimate to our animal quarters which were kept at 26-28°C with a 12 
hour light-dark cycle--lights on at 7 a.m. and off at 7 p.m. (Central 
Standard Time) for 7-15 days prior to use. Rats were given Purina Labo-
ratory Rat Chow (Ralston Purina Co., St. Louis, Missouri) and tap water 
ad libitu~ until approximately 4 p.m. the afternoon preceding experi-
ments when only the food was removed to allow for an overnight fast of 
about 18 hours. The rats weigl1ed 302 ~ 25 grams (mean + standard devi-
ation, N ~ 353) on the day of the experiments. 
B. Acute Lead Treatment 
In order to alter RES function, acute administration of lead 
acetate (PbAc) 5 mg/300 g rat was utilized since this dose has been 
shown to depress RES phagocytic function-(143,330). Powdered lead acetate 
(Code 5684, Mallinckrodt Chemical Works, St. Louis, Missouri) was pre-
pared in deionized distilled water to a concentration of 5 mg/ml on the 
day of the experiment. Depending on the experiment protocol, control 
treatment consisted of 1 ml of either 0.9% pyrogen-free saline (Travenol 
Laboratories, Inc., Deerfield, Illinois) or a 5 mg/ml solution of sodium 
acetate (NaAc) (Code 7372, Mallinckrodt) in deionized distilled water. 
~ats received the l ml injection iv via the dorsal vein of the penis 
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under light ether anesthesia (Anesthesia Grade, Mallinckrodt) induced 
in a glass ether jar. 
c. Colloidal Carbon Blockade 
As a second method of RES depression classic colloidal carbonblock-
ade (36) was induced by iv injection of 32 mg/100 g body weight of col-
loidal carbon. An inert biological ink was used--Pelikan Special Ink, 
Cll/143la (Gunther-Wagner, West Germany, Koh-I-Noor Radiograph, Inc., 
Bloomsbury, New Jersey) which is a colloidal suspension of homogeneous 
25 nm carbon particles (36, 180, 359) stabilized in a 4-5% fish glue 
gelatin solution (147, 247) with 1% phenol as a preservative (36, 152). 
To standardize the carbon concentration, the ink stock was diluted 
1:10,000 with deionized distilled water or 0.9% saline to permit densi-
metric determination of 3 ml aliquots using 1 x 1 em cuvettes in a Beck-
man Model DU Spectrophotometer (Beckman Instruments, Inc., Fullerton, 
California) at a wavelength of 675 nm. The conversion factor of 0.04 
OD U/mg carbon per liter (147) allowed calculation of the carbon con-
centration which was 83.5 mg/ml which is in agreement with the reported 
concentration of approximately 100 mg/ml (36). 
For blockade induction, the ink was diluted 1 part ink to 1.6 parts 
0.9% non-pyrogenic saline (Travenol) to achieve a concentration of 
32 mg/ml, pH adjusted to 7.4 and kept refrigerated until shortly before 
use. A sham blockade vehicle control for the ink diluent was obtained 
by ultracentrifugation of the ink at 25,000 x g in an International 
Preparatory Ultracentrifuge Model B-35 (International Equipment Co., 
Needham Heights, Massachusetts) which produced a supernatant that was 
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diluted as the carbon, oH = 7.4 and refrigerated. Sham and carbon 
solutions were prepared the evening before or day of the experiment. 
In carbon blockade experiments, the rats were separated into 3 groups. 
One group received a slow 3 ml iv injection of the 32 mg/ml colloidal 
carbon or 32 mg/100 g under light ether anesthesia. The 2 control 
groups were a sham vehicle group that was iv injected with 3 ml of the 
sham and an uninjected control group. 
D. Insulin Lethality Experiments 
Overnight fasted rats were divided into two groups, one 
received the non~lethal dose of 5 mg PbAc iv, the other pyrogen-free 
isotonic saline under light ether anesthesia. Immediately following the 
first injection, a second 1 ml subcutaneous injection of Lilly U-40 
IletirfiD regular insulin (Eli Lilly and Co., Indianapolis, Indiana) di-· 
luted to one of several concentrations with isotonic pyrogen-free saline 
was given in the subscapular region. Preparation of insulin solutions 
was done with non-glass labware to avoid losses due to non-specific 
binding. Dilutions ranging from 0.5 Ujml to 1.5 Ujml were utilized. 
The rats were then weighed, marked for identification and returned to 
their cages with only tap water provided. The number of hypoglycemic 
convulsive deaths which occured in the 24 hours after injection were 
tabulated. Significance of the difference in lethality between groups 
was assessed by the chi square test with Yates correction factor run on 
a PDP-12 Digital Computer (Digital Equipment Co., Maynard, Massachu-
setts). A "p" value less than 0.05 for chi square (104) was considered 
statistically significant. 
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E. Intravenous Glucose To 1 erance Testing_ 
Fasted rats were given either 5 mg PbAc or 5 mg NaAc 4 hours 
before the tolerance test. At t = -15 minutes, the animals were anes-
thetized ~ith 32.5 mg/kg Pentobarbital Sodium (Holmes Serum Co., Inc., 
Springfield, Illinois) administered as a 1 ml ip injection of a fresh 
pre-diluted solution of the 65 mg/ml sodium pentobarbital in isotonic 
nonpyrogenic saline. The level of anesthesia. was considered adequatev1h:n 
the ta i1 was 1 ir.~p and breathing was regular. Contra 1 ( C;) and succeed-
ing blood samples were taken from a tail snip. Using a sharp pair of 
scissors, just the tio of the tail was cut off and then the tail was 
milked to promote blood flow. Samples were collected directly into 250 
~1 heparinized, fluoride-treated microfuge tubes (Beckman). At time 
zero, after the control sampling, 200 mg of 0-glucose (Sigma Labora-
tories, St. Louis, Missouri) as 1 ml of 20% glucose in isotonic saline 
was administered iv. The glucose solution was prepared the night before 
to allow for mutarotation and kept refrigerated. Subsequent blood 
samples of about 0.2 ml were taken at 5 minute intervals from 5-45 
minutes. After the last sample, the blood was rapidly separated into 
plasma and cells in a Beckman Microfuge Model 152 and then frozen at ooc 
until glucose analysis. 
Plasma glucose concentrations v1ere determined using the t~ode 1 23l\ 
Yellow Springs Glucose Analyzer (Vella~ Springs Instrument Co., Inc., 
Yellow Springs, Ohio). This instrument measures glucose concentration 
in a 25 Jll sample by the amount of hydrogen peroxide produced in the 
glucose oxidase reaction (367). After thawing on ice and mixing of the 
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plasma layer, samples were done in triplicate except when the first 2 
readings differed by 2 mg/dl or less and then the mean calculated for 
each sample. To check for linearity of response, the analyzer was 
standardi?ed with 200 and 500 mg/dl glucose solutions (Yellow Springs). 
In order to analyze the data, the log10 of the plasma glucose 
concentrations was plotted against time in minutes for each rat. Then 
the best straight line through the 5-30 minute points was drawn and 
extrapolated to the ordinate so that the theoretical concentration at 
time zero (C0 ) could be determined. The time at which the glucose con-
centration was one half of the C0 was considered the half-time (t~) of 
glucose disappearance from the vascular compartment (298, 360). The k 
value or % glucose disappearance/min can be obtained by the formula 
k = 0.693/t~ x 100%, since during the initial 30 min measured,the 
change in plasma glucose with time appeared to be a single exponential 
function. The mean, standard deviation and standard error were calcu-
lated for c., C and t~. 
1 0 
The significance of the difference between 
the means was determined using Student's unpaired "t'' test with p < 0.05 
considered statistically significant done on the PDP-12 computer. 
F. Determination of Basal and Glucose-Stimulated Serum Insulin Levels 
in RES Depressed Rats 
Both basal and glucose-stimulated serum immunoreactive insulin 
levels (IRI) were measured in rats at various times after administration 
of an RES depressant and in controls. Sodium pentobarbital at a dose of 
32.5 or 43.3 mg/kg as a 1 ml ip injection of a freshly prepared dilution 
in isotonic nonpyrogenic saline was used. For basal samples, a cardiac 
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puncture of at least 1-3 ml was taken with a 5 ml syringe with a 20 
gauge needle at 15 min after induction of anesthesia or time zero. 
Glucose-stimulated serum samples were obtained 5 min after a 1 ml iv 
injection of 400 mg of D-glucose (Sigma) at time zero as 40% glucose in 
isotonic saline prepared the previous night and refrigerated. It has 
been shown that the peak insulin response to a glucose pulse occurs 
between 2-5 min following the stimulus (39, 267, 289) and 5 min also 
allowed for adequate mixing in the vascular compartment. After the 
cardiac puncture, the needle was removed from the syringe and blood was 
carefully transferred to glass tubes on ice to prevent hemolysis and 
allowed to clot. Clots were rung and the samples centrifuged, the serum 
removed and frozen at ooc in plastic vials. Serum glucose was measured 
using the YSI Glucose Analyzer as described previously. Serum IRI was 
determined on 4 replicates of the serum samples using the Phadebas Insu-
lin Test radioimmunoassay (RIA) kit (Pharmacia Laboratories, Inc., 
Diagnostics, Piscataway, New Jersey) as described below. Data \'Jere 
compared using Student's unpaired 11 t 11 test with p < 0.05 as the level 
of statistical significance. 
Serum samples were taken at 4 hours after 5 mg PbAc iv in overnight 
fasted rats because the RES is depressed (143) and metabolic changes 
have been noted at 4-6 hours after lead (140). For the carbon blockade 
studies 3 time points were chosen for measurement of basal serum glucose 
and insulin. Fasted rats were subjected to either a 4 or 8 carbon 
blockade since there is decreased RES function at 4-8 hours (12, 22, 14~ 
144, 152, 205, 213, 259, 301) and altered glucoregulation has been 
reported (144). An 18 hour carbon blockade was also used with a slight 
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difference in protocol in that rats were injected with carbonorvehicle 
and then fasted overnight for a total of 18 hours since both carbon and 
lead treatment before an overnight fast resulted in depressed hepatic 
gluconeogenesis (84, 144) and a trend toward recovery of phagocytic 
function after carbon blockad has been demonstrated within one day 
(22, 38, 103, 205). 
G. Immunoreactive Insulin Assay 
The Phadebas Insulin Test RIA kit (Pharmacia) vJas used to assay 
serum insulin (IRI) levels in rat serum samples. This RIA utilizes 
guinea pig anti-porcine insulin antibodies covalently bound to Sephadex 
particles as the solid phase which has several advantages such as ease 
of separation of bound and unbound insulin, high stability, high antigen 
binding capacity and little tendency for non-specific adsorption of 
proteins and polypeptides (356, 357). The concentration of insulin in 
an unknovm sample was evaluated by its capacity to compete with a fixed 
amount of labeled I-125 insulin for insulin antibody binding sites com-
pared to known concentration insulin standards. Since rat insulin is 
not readily available, a porcine insulin standard was used as a relative 
reference. 
Seven insulin standards of 3.2, 8, 16, 32, 80, 160 and 320 ~U/ml 
were prepared by both single and serial dilution steps (261). At the 
time of assay, serum was thawed and 250 ~1 of each well-mixed sample was 
mixed with 250 ~1 of the RIA kit buffer solution resulting in 500 ~1 
half-dilutions of the samples which was done for the following reasons: 
1) only a s~all quantity of serum was required for assay, 2) samples 
with high insulin levels were assayed at a more readable portion of the 
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standard curve and 3) dilution of high insulin samples made dilution of 
all samples obligatory because IRI measured by RIA is augmented by dilu-
tion (284). Four 100 ~1 replicates of each sample were assayed follow-
ing the manufacturer's procedure (261). Each time the RIA was done, 
triplicates of the buffer and duplicates of the standards, Pharmacia 
human refe~ence serum and pooled fed rat serum were run preceding and 
following the unknowns to check the reproducibility of the RIA. The 
coefficient of variation for samples was ~ 15%. Detailed information on 
the precision and accuracy of this RIA method is available (51, 341). 
Oxford Samplers (Oxford Laboratories, Inc., Foster City, California) 
were used for pipetting except for the Sephadex anti-insulin complex 
which was pipetted with a 1 ml Cornwall Syringe (Type BD, Becton, Dick-
inson, Rutherford, New Jersey) specially adapted with narrow polyethy-
lene tubing to prevent sedimentation. Assay mixtures containing 1~125 
insulin, sample and sephadex antibody complex in buffer were incubated 
24-36 hours in Pharmacia plastic 12 x 55 mm stoppered RIA tubes at room 
temperature on a horizontal RIA Shaker (Pharmacia). Incubation was 
terminated by centrifugation for 2 min in a 96 position IEC swinging 
bucket head at 1,500 x gin an IEC Model PR-J refrigerated centrifuge. 
After the stoppers were removed, the centrifugation was repeated at 
1,500 x g for 4 min,after which an adjustable collared pipette coupled 
to a water vacuum pump was used to aspirate the supernatant to approxi-
mately 5 mm from the bottom of the tubes. Three washes of the Sephadex 
particles were done with 2 ml of pH 7.0-7.5 isotonic saline kept on ice 
using a 5 ml Cornwall syringe followed by a 4 min centrifugation. The 
tubes containing the sediment were gently placed into uncapped 16 x 25 
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mm polystyrene gamma counting vials (Amersham Corp., Arlington Heights, 
Illinois) and counted for 10 or 20 min in a Searle/Analytic Model 1185 
Gamma Counter (Amersham/Searle, Arlington Heights, Illinois). 
In order to calculate the sample insulin concentrations, the mean 
count rate for each of the standards in cpm minus background was 
expressed as a percentage of the background corrected count rate of the 
zero samples which contained only buffer plus Sephadex antibody complex 
and I-125 insulin. A linear transform of the plot of the percent acti-
vity bound versus the log10 of the insulin concentration was calculated 
with a regression program run on the computer. Another program calcu-
lated the mean insulin concentration, standard deviation, standard 
error and coefficient of variation for each sample (51). The resulting 
concentrations were multiplied by 2 to correct for dilution of the 
samples. 
RESULTS 
Insulin Induced Hypoglycemic Lethality with Acute Lead Administration 
A series of experiments was done to determine whether RES depres-
sion by atute lead acetate administration would affect the incidence of 
insulin-induced lethal hypoglycemia. These data are displayed in figure 
l and table 1. Figure 1 shows that 5 mg lead acetate (PbAc) iv elevated 
the incidence of lethal hypoglycemic convulsions at the 4 insulin dos-
ages used. Both figure 1 and table indicate that the lower doses of in-
sulin, 0.5 and 0.75 U, though not lethal to saline controls did cause 
some deaths in lead-treated animals. However, statistically significant 
enhancement of lethality occurred with 1.0 U insulin (70%) and 1.5 U in-
sulin (95%) with lead administration. Comparison of the overall % 
lethality in the saline and lead-treated groups regardless of the insu-
lin dosage also reveals an increased sensitivity to insulin-induced 
hypoglycemic death. Lead acetate given alone is non-lethal at a dose of 
5 mg/300 g rat (135). 
Intravenous Glucose Tolerance After Acute Lead Administration 
In order to further evaluate the altered insulin sensitivity accom-
panying acute lead administration, iv glucose tolerance testing was done 
4 hours after 5 mg of lead acetate (PbAc) or sodium acetate (NaAc), using 
200 mg of glucose. Figure 2 demonstrates a 50% reduction in half-time 
(T12) of glucose disappearance, i.e. increased glucose tolerance in the 
lead treated rats. The basal or initial plasma glucose levels (Ci) of 
the 2 experimental groups \vere not significantly different (table 2). The 
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TABLE l 
INSULIN HYPOGLYCEMIC LETHALITY WITH 
ACUTE LEAD ADMINISTRATIONa 
Experimental Number Insulin Dose 
Group of Rats (Units/Rat) 
Control, 0.9% Saline 20 0.50 
10 0.75 
20 1.00 
20 l. 50 
70b 
Lead Acetate, 5 mg 30 0.50 
10 0.75 
30 1.00 
20 l. 50 
90b 
Lethality 
0% 
0% 
5.0% 
40.0% 
12.8% 
16 0 7% 
30.0% 
70.0%c 
95.0%c 
53.3%c 
a Overnight fasted rats received a l ml iv injection of 
either 5 mg/ml lead acetate or 0.9% saline immediately 
followed by a l ml injection of insulin sc. Lethality 
was recorded at 24 hours. 
b Total lethality of all rats in the experimental group 
regardless of insulin dose. 
c p<O.OOl as compared to control groups using the Chi 
Square test with Yates correction factor. 
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FIGURE 1 
EFFECT OF ACUTE LEAD ADMINISTRATION ON 
INSULIN HYPOGLYCEMIC LETHALITY 
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ALL DOSES 
Overnight fasted rats received a 1 ml iv injection of either 5 mg 
lead acetate or 0.9% saline immediately follov1ed by a 1 ml insulin injec-
tion sc of one of 4 dosage levels. Lethality was recorded at 24 hours. 
N = the number of rats in the group. The 2 bars on the far right show % 
lethality of all rats in the experimental group regardless of insulin dose 
(all doses). Statistical significance of the data was evaluated using 
the Chi Square test with Yates correction factor. N.S. = not significant. 
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TABLE 2 
GLUCOSE TOLERANCE (200 mg iv) AFTER ACUTE LEAD ADMINISTRATIONa 
Experimt::ntal 
Group· 
Plasma Glugose Plasma Glucose 
Number Basal (C;) At Time Zero 
of Rats (mg/dl) (C0 )C (ng/dl) 
Half-Time (TO;;) 
Glucose Disap-
pearance (min) 
--------------- ----------------------------
Control, 
Sodium Acetate 10 
5 mg 
Lead Acetate 
5 mg 
P-Va 1 uee 
10 75 + 4 
N.S. 
305 + 10 49 + 6 
359 + 21 24 + 3 
0.032 <0.001 
a Overnight fasted rats received a 1 ml iv injection of either lead 
acetate or sodium acetate (5 mg/ml) 4 hours before iv glucose 
tolerance testing. 
b Plasma glucose immediately before injection of 200 mg glucose iv 
at 0 min. 
c Value of plasma glucose at time= 0 min obtained by extrapolation of 
the line -- 10910 plasma glucose vs. time -- to 0 min. 
d f1ean + standard error. 
e Group data were compared using the unpaired Student 1 S "t" test. 
P = <0.05 was considered statistically significant. N.S. = not signi-
fi cant. 
FIGURE 2 
EFFECT OF ACUTE LEAD AmHNISTRATION ON THE 
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400 
Co 
300 
200 
'::!100 
:!:! 90 ~ 80 
.... 70 Ci 
w 
U) 60 
0 
(.J 50 
:::1 
..J 
" 40 
C( 
~ 30 
C( 
..J 
D. 
20. 
T'/2 =49±6 MIN 
T'/2=24±3 MIN 
•• - ..... PbAc (10) 
10,._-P~-~~~-~~~~~ 
0 5 10 15 20 25 30 35 40 45 
TIME (MIN) 
50 
Overnight fasted rats received a 1 ml iv injection of either 5 mg 
lead acetate or sodium acetate 4 hours before iv glucose tolerance test-
ing. c. is the mean basal plasma glucose of the experimental groups 1 
immediately before iv injection of 200 mg glucose at 0 min. Note that 
the lines are not drawn through the mean plasma glucose concentration at 
each time point but were drawn utilizing the mean theoretical plasma 
glucose concentration at time zero (C0) and the mean half-time of glu-
cose disappearance (T~) of the 10 rats in each group. 
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group mean C , the glucose level at time zero, was significantly higher 0 
in the PbAc group compared to the NaAc group (table 2). 
Basal and ~ucose-Stimulated Serum Glucose and Insulin Levels 4 Hours 
After Acute Lead Administration 
Since the preceding experiments suggested a role for the RES in 
modulating insulin activity, actual measurements of serum glucose and 
insulin (IRI) levels were done both in the basal fasting state and 5 min 
after 400 mg glucose iv. As shown in table 3 and figure 3, RES depression 
by administration of PbAc 4 hours prior raised basal serum insulin levels 
(p = 0.018) although serum glucose was unchanged, resulting in the eleva-
tion of the I/G (insulin to glucose) ratio. At 5 min after 400 mg glucose 
iv (table 4 and figure 4), there was a 6-fold increment in serum insulin 
levels (p < 0.001). Though serum glucose was higher in the PbAc group, 
the I/G ratio still showed a 6-fold increase compared to that for NaAc 
controls. This suggests an exaggerated insulin response to the prevailing 
glucose levels. 
Basal and Glucose-Stimulated Serum Glucose and Insulin Levels After 
Colloidal Carbon Blockade 
Further investigation of the effect of altered RES function on insu-
lin regulation was carried out using inert non-toxic colloidal carbon (~8~ 
to induce a state of blockade or decreased phagocytic function (36). At 
4 hours after injection of 32 mg/100 g of colloidal carbon, there was a 
decrease in basal serum glucose levels compared to the uninjected controls, 
(p = 0.016) but not the sham vehicle controls (table 5). The 4 hr carbon 
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TABLE 3 
SERUM GLUCOSE AND INSULIN LEVELS 4 HOURS AFTER ACUTE LEAD ADMINISTRATIONa 
Serum b Experimenta.l Number Glucose Serum IRI 
Group of Rats (mg/dl) (f.IU/ml) I/Gc 
Control, 
Sodium Acetate 8 116 + 2d 9.4 + 0.5 0.082 + 0.005 
5 mg 
Lead Acetate 5 mg 8 110 + 3 15.2 + 2.1 0.139 + 0.022 
P-Value e N.S. 0.018 0.024 
a A l ml iv injection of 5 mg/ml lead acetate or sodium acetate was 
administered to fasted rats 4 hours before blood sampling. 
b Immunoreactive insulin (IRI) was measured by the Phadebas method. 
c Ratio of the serum IRI in f.IU/ml to serum glucose in mg/dl. 
d Mean + standard error. 
e Group data were compared using the unpaired Student•s 11 t" test. 
P < 0.05 was considered statistically significant. N.S. = not signi-
ficant. 
FIGURE 3 
EFFECT OF ACUTE LEAD ADMINISTRATION ON 
SERUM GLUCOSE AND INSULIN LEVELS 
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A l ml iv injection of either 5 mg lead acetate or sodium acetate 
was administered to fasted rats 4 hours before blood sampling. Basal 
serum glucose and insulin (IRI) levels are shown. I/G is the ratio of 
the serum IRI in ~U/ml to serum glucose in mg/dl. N = number of rats 
per group. 
TABLE 4 
EFFECT OF ACUTE LEAD ADMINISTRATIONa ON SERUr·1 GLUCOSE 
AND INSULIN LEVELS 5 MIN AFTER 400 mg GLUCOSE iv 
·• 
Experimental Number Serum Serum IRib 
Group of rats Glucose ( llU/ml) I/Gc 
(mg/dl) 
Control~ 
569 + gd Sodium Acetate 8 34.6 + 4.7 0.062 + 0.009 
5 mg 
Lead Acetate 8 652 + 27 235.5 + 17.4 0.362 + 0.024 
5 mg 
P-value 0.011 < 0. 001 < 0. 001 
a A 1 ml iv injection of 5 mg/ml lead acetate or sodium acetate was 
administered to fasted rats 4 hours before the time of glucose in-
jection. Blood samples were taken at 5 min after 400 mg glucose iv. 
b Immunoreactive insulin (IRI) was measured by the Phadebas method. 
c Ratio of the serum IRI in llU/ml to serum glucose in mg/dl. 
d Mean + standard error. 
e Group data were compared using the unpaired Student's "t" test. 
P < 0.05 was considered statistically significant. 
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FIGURE 4 
EFFECT OF ACUTE LEAD ADMINISTRATION ON SERUM 
INSULIN LEVELS 5 MIN AFTER GLUCOSE [400 mg iv] 
~.40 
300 
I 250 .30 [] 
INSULIN 200· 
[uU/ml] 
150• 
100 
50 Jl ~t ~~~~~ 0...__ lliiiilo----
N= 8 8 
GROUP: NaAc PbAc 
SERUM (4 HRS PRIOR) 
GLUCOSE: 
[mg/dll 
569±9 652±27 
1/G 
.20 
t".10 
55 
A 1 ml iv injection of either 5 mg lead acetate or sodium acetate 
was administered to fasted rats 4 hours before the time of glucose injec-
tion. Blood samples were taken 5 min after 400 mg glucose iv. Serum 
insulin (IRI) levels and the ratios (I/G) of the serum IRI (~U/ml) to 
serum glucose (mg/dl) are depicted. N =number of rats per group. 
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TABLE 5 
SERUM GLUCOSE AND INSULIN LEVELS AFTER 
COLLOIDAL CARBON BLOCKADEa 
Experimental Serum b Serum IRI 
Group Glucose ( JlU/rnl) I/Gc 
(mg/dl) 
A) Uninjected Control 
l) 4- hr prior 87 + 4 (8)d 32.4 + 4.0 ( 8) 0.385 + 0.064 (8) 
2) 8 hr prior 103 + 4 ( 15) 20.9 + 1.5 ( 14) 0.213 + 0.019 ( 14) 
3) 18 hr prior 68 + 3 (6) 26.8 + 2.6 (4) 0.384 + 0.033 (4) 
B) Sham Vehicle Control 
1 ) 4 hr prior 80 + 5 (8) 20.9 + 2.9 (8) 0.277 + 0.049 (8) 
2) 8 hr prior 106 + 4 ( 14) 20.7 + 2.0 ( 15) 0.193 + 0.021 ( 14) 
3) 13 hr prior 77 + 2 ( 16) 27.0 + 2.3 (6) 0.350 + 0.028 (6) 
C) Carbon Blockade 
1 ) 4 hr prior 65 + 7 (8) 29.8 + 0.8 (7) 0.460 + 0.048 (7) 
-
2) 8 hr prior 108 + 4 ( 17) 39.8 + 2.8 (17) 0.37!3 + 0.033 ( 17) 
3) 18 hr prior 67 + 3 (8) 27.9 + 2.7 (8) 0.427 + 0.050 (8) 
-----
a Overnight fasted rats received 32 mg/100 g of colloidal carbon (3 ml 
of 32 mg/ml) or equivalent volume of vehicle iv or no treatment either 
4 or 8 hr prior to blood sampling. For 18 hr blockade, fed rats were 
injected and then fasted 18 hr prior to blood sampling. 
b Immunoreactive insulin (IRI) was measured by the Phadebas method. 
c Ratio of the serum IRI in JlU/ml to serum glucose in mg/dl. 
d Mean+ standard error (number of animals). 
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TABLE 5 (cont.) 
SERUM GLUCOSE AND INSULIN LEVELS AFTER 
COLLOIDAL CARBON BLOCKADEa 
Critical C . e P-values ompan sons 
Serum Glucose A-1 vs. C-l 0.016 
A-3 vs. B-3 0.032 
B-3 vs. C-3 0.016 
Serum Insulin A-1 vs. 8-l 0.035 
B-1 VS. C-1 0.011 
A-2 vs. C-2 < 0. 001 
8-2 vs. C-2 < 0. 001 
I/G B-1 vs. C-1 0.019 
A-2 VS. C-2 < 0. 001 
B-2 vs. C-2 < 0. 001 
e Group data were compared using the unpaired 
Student's "t" test. Only statistically 
significant comparisons with p-value < 0.05 
are given. 
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rats also showed an elevation in basal serum insulin (p = 0.011) in 
comparison to the sham vehicle controls resulting in an elevated I/G ratio 
(figure 5, table 5). But uninjected control basal serum insulin levels 
were higher than those of the sham vehicle group (p = 0.035) and not 
statistically different from those of the carbon-treated rats (table 5, 
figure 5). In contrast to the 4 hr carbon blockade study, 8 hr carbon 
blockade resulted in a highly significant doubling of basal serum insulin 
concentration compared to both control groups (p < 0.001) although the 
serum glucose concentration remained the same in all 3 groups (table 5, 
figures 5 and 6) resulting in a doubling of the I/G ratio. Table 6 and 
figure 7 display the effect of an iv 400 mg glucose stimulus on serum 
insulin levels 5 min after injection in the 8 hr carbon blockade group. 
An even more exaggerated 3-fold serum insulin increase occurred compared 
to both sham vehicle and uninjected controls {p < 0.001). Serum glucose 
levels were similar in all 3 groups, however, resulting in a corresponding 
rise in the I/G ratio (table 6, figure 7) in the 8 hr carbon blockade 
animals after glucose. In the fed rats which received carbon and were 
then fasted 18 hr (18 hr carbon blockade), basal serum glucose, insulin 
and the I/G ratios were not significantly different from the controls as 
seen in figure 5 and table 5. 
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EFFECT OF ALTERED RES FUNCTION 
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I COLLOIDAL CARBON 
Overnight fasted rats received colloidal carbon (32 mg/100 g) iv, 
an equivalent volume of vehicle iv or no treatment either 4 or 8 hours 
prior to blood sampling. For the 18 hour group, fed rats were injected 
and then fasted 18 hours prior to blood sampling. Basal serum insulin 
(IRI) levels are depicted. N = number of rats yielding samples in each 
group. 
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FIGURE 6 
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Data from the 8 hr colloidal carbon injected (carbon blockade), 
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sham vehicle controls (sham blockade) and uninjected controls (Figure 5 
and Table 5) are shown in detail. Serum glucose and insulin (IRI) levels 
are depicted. I/G is the ratio of the serum IRI in vU/ml to serum glu-
cose in mg/dl. N =number of rats yielding samples in each group. 
TABLE 6 
EFFECT OF 8 HOUR CARBON BLOCKADEa ON SERUM GLUCOSE AND 
INSULIN LEVELS 5 MIN AFTER 400 mg GLUCOSE iv 
Experimental Serum Serum !Rib 
Group Glucose ( llU/n1) I/Gc 
(mg/d1) 
Uninjected control 544 + 21 ( 16) d 38.2 + 2.2 ( 14) 0.077 + 0.005 
Sham Vehicle 
Control 531 + 17 ( 17) 34.6 + 2.1 ( 17) 0.065 + 0.004 
Carbon Blockade 539 + 28 ( 17) 116.6 + 9.7 (l7)e 0.226 + 0.022 
61 
( 14) 
(17) 
{17)e 
a Overnight fasted rats received 32 mg/100 g of colloidal carbon (3 ml 
of 32 mg/ml) or equivalent volume of vehicle iv or no treatment 8 hr 
before the time of glucose injection. Blood samples were taken at 5 min 
after 400 mg glucose iv. 
b Immunoreactive insulin (IRI) vJas measured by the Phadebas method. 
c Ratio of the serum IRI in llU/ml to serum glucose in mg/dl. 
d Mean + standard error (number of animals). 
e P < 0.001 as compared to either the uninjected control or sham vehicle 
control groups using the unpaired Student 1 s 11 t 11 test. P < 0.05 considered 
statistically significant. 
FIGURE 7 
EFFECT OF CARBON BLOCKADE ON SERUM INSULIN 
LEVELS 5 MIN AFTER GLUCOSE [400 mg iv] 
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Overnight fasted rats received colloidal carbon (32 mg/100 g --
carbon blockade) iv, an equivalent volume of vehicle (sham blockade) iv 
or no treatment 8 hr before the time of glucose injection. Blood samples 
were taken 5 min after 400 mg glucose iv. Serum insulin (IRI) levels and 
the ratios (1/G) of the serum IRI (vU/ml) to serum glucose (mg/dl) are 
depicted. N =number of rats yielding serum insulin samples in each 
group. 
DISCUSSION 
Effect of Acute Lead Administration on Insuli~oglycemic Lethality_. 
The toxic effects of lead were recognized since antiquity and des-
criptions of acute lead poisoning date back to Hippocrates and Nicander 
(69, 182). Starting from the seventeenth century the more subtle as-
pects of lead poisoning have been investigated, especially because lead 
is an ubiquitous environmental contaminant which primarily affects chil-
dren with pica causing a constellation of hematological, neuromuscular, 
gastrointestinal and central nervous system disorders (69, 182, 234). 
One of the more ominous of the reported consequences of lead ingestion 
in man is a fatal shock episode (182). 
Selye et ~.,while investigating the pharmacological actions of 
heavy metals observed that iv administration of a non-lethal 5 rng quan-
tity of lead acetate to rats resulted in a 100,000-fold increase in 
endotoxin susceptibility (288). The lead enhancement of endotoxin shock 
lethality was maximal when both agents were administered sin1ultaneously 
(80, 288). Filkins and Buchanan utilized this synergism to develop an 
endotoxin bioassay (53, 135, 143). Selye's hypothesis for the lead 
effect was that it produced a blockade of the RES (288). Subsequent 
studies substantiated that hypothesis since a non-lethal dose of lead 
acetate--5 mg/300 g rat--did depress the RES clearance of colloidal car-
bon (143) and l31I-labeled lipid emulsion (330). Kupffer cell phago-
sornes containing electron-dense material (lead?) have been identified in 
both hepatic and splenic macrophages along with later hepatic ultra-
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structural changes (80, 190) after lead administration. It has also 
been reported that parenterally administered lead salts attached pri-
marily to erythrocyte membranes with the remainder r.apidly precipitating 
to form colloidal particles which vJere distributed in the 1 iver, spleen 
and bone marrow (84). 
The mechanism of the lead sensitization to endotoxin remained a 
mystery. The degenerative morphological changes noted in hepatic Kupf-
fer and parenchymal cells did not correlate with the time response of 
lead-induced endotoxin hypersensitivity (80, 190). Furthermore, Filkins 
and Buchanan demonstrated that lead administration altered neither the 
~vivo vascular clearance nor the in vitro hepatic detoxification of 
endotoxin (143). These investigators interpreted the data as indicating 
that a 11 metabolic lesion 11 was the basis of lead's action (143). 
The combination of lead and endotoxin produced hypoglycemia, glyco-
gen depletion and depression of gluconeogenesis in baboons (80), mice 
(272) and rats (140) all characteristic of endotoxin shock (26, 52, 54, 
55, 56, 79, 87, 134, 140, 145, 146, 172, 188,.189, 225,263,272, 290,-291' 
292, 303, 363, 364). Further experimentation revealed that lead acetate 
alone depressed gluconeogenesis from lactate, pyruvate and alanine both 
1!:!_ vivo and iQ_ vitro using isolated hepatocytes (84, 140). Lead also 
produced glycogen depletion (140, 272). In vitro addition of lead ace-
tate to isolated hepatocytes had no effect on gluconeogenesis (84), 
suggesting that the lead-induced alterations in glucose metabolism must 
be mediated by another substance. 
With the knowledge that insulin is the dominant physiologic regula-
tor of carbohydrate metabolism (97, 132), a lethality study was done to 
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determine whether the metabolic changes noted after RES depression by 
' lead acetate might be due to alterations in insulin responsivity or 
regulation. A series of lethality experiments was done to evaluate the 
susceptibility to insulin-induced hypoglycemic convulsive death in lead-
treated rats versus saline controls. Four different dosages of insulin 
were utilized randomly in the 2 groups of fasted rats. As depicted in 
both table 1 and figure 1, at every dose level, insulin administration 
resulted in hypoglycemic convulsions followed by death in a portion of 
the lead-treated rats. In comparison, note that both the 0.5 and 0.75 U 
doses of insulin were non-lethal in the saline treated control animals. 
Statistically significant elevations in lethality did occur with lead 
treatment at the higher dosages of 1.0 and 1.5 U of insulin. Comparison 
of the results in the 2 experimental groups regardless of insulin dose 
also revealed an increase in lethality in the lead acetate group. All 
deaths occurred 4 to 12 hours following insulin injection and were pre-
ceded by the signs and symptoms of hypoglycemia i.e. loss of conscious-
ness, convulsive spasms and coma (124). 
These results confirmed and expanded upon an earlier study by 
Buchanan and Filkins, in which leat-treated rats displayed increased 
sensitivity to one dose level of exogenous insulin and to endogenous in-
sulin release induced by tolazamide as manifested by an elevation of the 
incidence of lethal hypoglycemia (52). Recently Filkins demonstrated 
that RES depression by colloidal carbon blockade markedly enhanced sen-
sitivity to lethal insulin hypoglycemia in rats (142, 144). Since acute 
endotoxin administration produces an RES depressed state (20, 23, 179, 
192, 323), the reports of Pieroni and Levine (263) and Buchanan and 
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Filkins (55) that endotoxin shock lethality was increased by admini-
stration of insulin or beta cell stimulants provide additional support 
for the notion that RES depression results in altered responsivity to 
insulin. Shands et ~- also reported endotoxin-induced insulin sensi-
tivity in mice; however, their results are difficult to interpret 
because the mice were infected with Mycobacterium bovis BCG prior to the 
experiment (292). Although insulin tolerance testing in rats given the 
RES depressants colloidal carbon (142), lead (52) or endotoxin (142) 
demonstrated an enhanced hypoglycemic response to exogenous insulin as 
shown by blood or plasma glucose measurements, the mechanism of this 
insulin sensitization remained unexplained. 
One potential explanation for this phenomenon is an alteration of 
tissue responsiveness to insulin. This possibility has not been explor-
ed in depth. A second explanation could be a failure or diminished 
effect of insulin counter-regulatory systems such as glucagon, growth 
hormone, corticosteroids and the sympathetic nervous system (97, 124). 
Glucagon insufficiency has been proposed as a cause for hypoglycemia 
but it is a rare occurrence (124). The role of glucagon in glucose 
regulation has recently been minimized since glucagon has an evanescent 
effect on hepatic glucose production and no known effect on peripheral 
glucose disposal (68, 132). Sacca et ~l· reported that even though 
glucagon was involved in the metabolic reaction to insulin-induced hypo-
glycemia in the rat, its role was not essential because rats rendered 
glucagon-deficient tended to recover normally (281). Growth hormone is 
normally released during hypoglycemia (97) and a deficit in its secre-
tion has been demonstrated only in ateliotic dwarfs (124). A deficiency 
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in glucocorticoids can exacerbate or even casue hypoglycemia but adrenal 
or pituitary hypofunction would have to be demonstrated (124). Finally 
the activity of the sympathetic nervous system normally is increased in 
a stressful state such as hypoglycemia (97) and its dysfunction is more 
likely the result of rather than the cause of a hypoglycemic reaction 
(124). A third possibility for the sensitization to insulin manifested 
after RES depression could be the production of additional non-suppres-
sible insulin-like activity or NSILA; however, Eigenmann and associates 
reported that NSILA levels did not change following manipulations of 
blood sugar in the dog and they concluded that in physiological terms 
NSILA appears to be only an insulin-like growth factor (114). The 
fourth and most obvious explanation for the increased insulin lethality 
with decreased RES function is a defect in insulin regulation. The hypo-
glycemia resulting from the insulin increase in the animal would suppress 
pancreatic insulin secretion (97, 124) pointing to a potential defect in 
insulin removal or degradation. A decrease in insulin extraction by the 
key insulin degrading organs, especiallv the liver (133), could promote an 
elevation of circulating insulin in the RES d~~ressed animal as has been 
demonstrated in the obese-hyperglycemic mouse (207). Before the advent 
of modern radioimmunoassay methods, insulin was assayed by noting the 
incidence of severe hypoglycemic reactions in mice (368), lending fur-
ther support to the notion of a defect in insulin extraction and cata-
bolism in the RES depressed state. 
Intravenous Glucose Tolerance After Acute Lead Administration. 
In order to further evaluate the altered insulin status accompany-
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ing RES depression, iv glucose tolerance was measured in rats 4 hours 
after either lead acetate or sodium acetate treatment. As displayed in 
table 2 and figure 2, the lead-treated group demonstrated an increase 
in glucose tolerance with a reduction of the half-time of glucose dis-
appearance from 49 min in the sodium control group to 24 min in the 
lead group. The basal fasting plasma glucose values in the two groups 
were not significantly different (table 2) and were in the appropriate 
range for fasting (360), indicating that the rats were in a normoglyce-
mic state immediately before tolerance testing. 
The iv glucose tolerance test was used because, even though it is 
a relatively non-specific test, the results are readily interpreted and 
the decrease in plasma glucose is significantly influenced by the effect 
of insulin on hepatic glucose production and peripheral tissue glucose 
uptake (132, 298, 360). Therefore, changes in glucose tolerance can be 
directly related to insulin activity and barring any evidence of insulin 
resistance, to the insulin levels present after the glucose stimulus 
(298). Normally an iv infusion of glucose results in two phases of pan-
creatic insulin secretion, a rapid phase beginning 1 min after the start 
of the infusion and lasting about 3 to 5 min followed by a slower phase 
beginning approximately 10 min after the start of the infusion (39, 267, 
289). Stress is a significant cause of glucose intolerance and there-
fore false tolerance test results (360, 365). Increased sympathetic 
activity and catecholamine release have been shown to cause inhibition 
of pancreatic insulin output, retardation of glucose utilization and 
accelerated appearance of endogenous glucose (289, 295, 365). In order 
to eliminate this variable, the rats were anesthetized with sodium 
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pentobarbital, allowing a 15 min waiting period before the start of the 
test to insure that they were fully relaxed and asleep with a regular 
breathing pattern. The dose of glucose used was 200 mg/300 g or 0.666 
g/kg which is within the accepted range of glucose dosages used for 
glucose tolerance testing (56, 87, 144, 295, 360). 
In this study, RES depression by acute lead treatment increased 
glucose tolerance as shown by a 50% reduction in the half-time of 
glucose disappearance from the vascular compartment. This data agreed 
with the results of another study by Filkins and Buchanan in which they 
demonstrated that decreasing RES function by colloidal carbon blockade 
caused a 3-fold reduction in the glucose disappearance half-time (145). 
Thus in 2 different models of RES depression there was physiological 
evidence of an increase in insulin activity. In interpreting these 
data, it should be considered that there is no evidence at present for 
an altered response to insulin at the tissue level with RES depression 
alone. It is probable that the increased glucose tolerance resulted 
from elevated circulating insulin levels. 
Several other alterations in glucose metabolism that hint of a 
functional hyperinsulinemic state have been reported with reduced RES 
function. Depression of hepatic gluconeogenesis was observed after 
acute lead administration (84, 140), colloidal carbon blockade (144) 
and endotoxin administration (56, 145, 146, 188, 225, 291 ). The 
occurrence of increased disappearance or utilization of glucose in 
endotoxin shock is well known (56, 188, 363). Measurements of in vivo 
whole body glucose oxidation after lead (Filkins, unpublished results), 
carbon blockade (144) and endotoxin (56, 134) demonstrated increased 
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insulin activity at the tissue level. The endotoxin-induced hypercata-
bolism of glucose could be eliminated by the use of dexamethasone (134) 
or by rendering the rats insulinopenic by either mannoheptulose or 
streptozotocin treatment (56). Hypercatabolism of glucose by various 
tissues taken from endotoxic rats was also diminished by anti-insulin 
agents (134). The combination of decreased gluconeogenesis and increas-
ed glucose utilization in endotoxemia ultimately results in hypoglycemia 
(26, 55, 56, 134, 145, 146, 172, 188, 189, 290,303, 36~. Buchanan, in his 
investigation of the metabolic alterations of endotoxemia in the rat, 
performed ip glucose tolerance tests with insulin measurements in groups 
of rats; he noted no alterations of glucose tolerance despite an exag-
gerated insulin response (56). Endotoxic rats receiving ialine also 
displayed an elevation of serum insulin levels (56), strengthening the 
notion that RES depression may foster a hyperinsulinemic state. 
Basal and Glucose-Stimulated Serum Glucose and Insulin Levels After RES 
Depression. 
With the knowledge that both hyperinsulinemia and hypoglycemia were 
present in the endotoxin-treated rat (56) and since acute endotoxin ad-
ministration causes RES depression (20, 23, 179, 192, 323), which is 
characterized by altered glucose regulation suggestive of a hyperinsuli-
nemic state (table 2) (56, 84, 134, 140, 144, 145, 146, 188, 225, 291, 
363), it seemed logical to investigate the effect of RES depression on 
serum glucose and insulin levels. Two models of RES depression were 
investigated: acute lead treatment and colloidal carbon blockade. 
These models were utilized because of the previous data on altered glu-
coregulation and because they are non-lethal (135, 180) in comparison to 
71 
endotoxin which can cause a fatal shock episode. The effect of 
colloidal carbon would be especially significant since this is a classi~ 
inert, non-toxic RES test and blockade substance (20, 21, 36, 179, 180, 
309) which should not produce any deleterious effects in addition to RES 
depression. In contrast, acute treatment of 300 g rats with 5 mg lead 
acetate, though non-lethal (135), might have some toxic effects since 
heavy metals can combine with sulfhydryl and other groups to inhibit 
various enzyme systems and perhaps altering membrane permeability {182, 
333). Both serum glucose and insulin were measured in the basal fasting 
state and 5 min after 400 mg of glucose iv, which allowed for adequate 
mixing and equilibration time in the vascular compartment, and should 
reflect the rapid phase of pancreatic insulin secretion (39, 267, 289). 
Since blood sampling was by cardiac puncture, the rats were anesthetized 
to minimize any influence of stress on insulin and glucose levels (289, 
295, 365). 
Table 3 and figure 3 present the basal fasting serum glucose and 
insulin levels 4 hours after acute lead administration. Filkins and 
Buchanan verified that RES function is decreased at that time {143). 
Serum glucose levels were unchanged and normal [60-120 mg/dl] (36~yet 
serum immunoreactive insulin or IRI showed a statistically significant 
elevation in the lead group. This resulted in an elevation of the insu-
lin to glucose ratio (I/G) which indicates that there was an abnormally 
large amount of circulating insulin in the lead-treated rats relative to 
the pancreatic glucose stimulus. This ratio has been shown by Merimee 
and Tyson to be superior in the diagnosis and differentiation of hypo-
glycemia and hyperinsulinemia due to an insulinoma (228). Both the 
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sodium and lead-treated rats had insulin levels within the range of 
reported fasting plasma or serum IRI levels of nearly 0 ~U/ml to 66 ~U/ 
ml (51, 162, 289). 
Since basal insulin levels were higher in the RES depressed lead 
group, the effect of a 5 min glucose stimulation on serum IRI and glu-
cose was investigated. As shown in table 4 and figure 4 serum insulin 
levels were incremented 6-fold in the 4 hr lead treatment group compared 
to the sodium control group. Serum glucose levels were elevated in the 
lead-treated rats; however, there was still a 6-fold elevation in the 
1/G ratio. Therefore, the lead-treated rats had markedly elevated serum 
insulin levels in relation to the serum glucose concentration present 
after glucose administration supporting the data on ba$al insulin and 
glucose in table 3 and figure 3. 
Rather than choose only one time point in the study on insulin and 
glucose levels after colloidal carbon blockade, an attempt was made to 
find some correlation between RES function and insulin status. Basal 
serum glucose and insulin levels were measured at 4, 8 and 18 hours 
after colloidal carbon blockade and are given in table 5. Three experi-
mental groups were used in this study: uninjected control rats, sham 
vehicle-injected rats which received a 3 ml iv injection of the vehicle 
from the colloidal carbon suspension and the carbon blockade group which 
received 32 mg/100 g body weight of colloidal carbon as a 3 ml iv injec-
tion. Although it might be argued that the sham and carbon groups alone 
would have been sufficient, the uninjected groups was added to check for 
any influences of the injection procedure e.g. stress or possible volume 
expansion and to provide normal values. 
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At 4 hours after carbon administration, the carbon-group had a 
decrease in serum glucose in comparison to the uninjected controls but 
not the sham vehicle-injected control group. There are 2 possible 
explanations for these data. Four hours after a blocking dose of carbo~ 
the dose is still being cleared by the RES (227, 370) and the increased 
glucose utilization by the actively endocytizing macrophages (2, 8, 45, 
70, 208, 210, 264, 265) may cause a lowering of the serum glucose con-
centration. The other factor in the sham vehicle-injected rats could be 
the 3 ml iv injection of vehicle which contains a fish glue gelatin 
(147, 247) protein solution that may remain in the vascular compartment 
for several hours. Dilution may have reduced the 4 hour serum glucose 
slightly in the sham group, making the carbon group appear hypoglycemic 
compared to only the uninjected rats and not the shams. The hormonal 
systems which maintain blood glucose (124, 281, 360) could also be 
acting to counter the lowering of serum glucose by dilution, preventing 
an even larger decrease. Serum insulin levels and the I/G ratio were 
elevated in the 4 hr carbon rats compared to the sham rats but not the 
uninjected rats (table 5 and figure 5). In fact the serum insulin 
levels in the uninjected rats were higher than those of the sham control 
rats. Again the most likely explanation for the diminished serum in-
sulin levels in the sham vehicle-injected rats is possible dilution of 
the circulating insulin. The albino rat has an estimated blood volume 
of about 5 ml/100 g body weight (28, 193, 258). Since the rats weighed 
about 300 g, the blood volume should be approximately 15 ml and, assum-
ing a hematocrit of 45 (28), the plasma or serum volume should be about 
8.25 ml. Therefore, a 3 ml injection of a protein solution couldenlarge 
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the plasma volume by up to one-third. For example, the insulin levels 
in the sham group, which were 20.9 ~ 2.9 ~U/ml, might have been approx-
imately 28 ~U/ml without the injection of vehicle and thus similar to 
the uninjected control insulin levels of 32.4 ~ 4.0. This dilution 
effect may even have lowered the serum IRI in the 4 hr carbon group. 
The results of the 4 hour blockade study did not permit any firm conclu-
sions to be made. 
Because the 4 hour study hinted of a possible increase in serum 
insulin levels in the carbon injected rats, which may have been entering 
a state of RES blockade (12, 152, 205, 259, 369), the next study inves-
tigated the effect of an 8 hour carbon blockade on serum glucose and 
insulin levels. Several workers have found that at 6 to 12 hours after 
a blocking dose of colloidal carbon, RES endocytic activity is depressed 
in several species (12, 152, 213, 259, 369, 370). The results of the 
8 hour carbon blockade are displayed in table 5 and figure 6. 'In con-
trast to the 4 hr study, 8 hr carbon blockade resulted in a doubling of 
basal fasting serum insulin levels compared to both the sham and unin-
jected control groups. The serum glucose levels were unchanged causing 
a doubling of the I/G ratio reminiscent of the results in the lead stud~ 
After 400 mg of glucose iv, the rats subjected to an 8 hr carbon 
blockade had a 3-fold elevation in serum IRI levels. As in the basal 
state, the serum glucose values were similar in all 3 experimental 
groups as seen in table 6 and figure 7. Consequently, the l/G ratios 
in the carbon blockade group also showed a 3-fold elevation. Since 
colloidal carbon blockade is the best model for a "pure" RES depressed 
state, the results of the basal and glucose stimulation studies clearly 
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demonstrated that during RES depression there is an increase in the 
circulating serum IRI. The fact that normal serum glucose levels were 
maintained despite the hyperinsulinemic state is not surprising if one 
considers that the various components of the glucoregulatory system 
(124, 360) may be capable of counteracting the insulin increase. In 
fact these data may indicate that those systems are functional in the 
RES depressed animal. An elevation of glucagon levels could stimulate 
pancreatic insulin secretion (360); however, glucagon levels were not 
measured in this study preventing any conclusions regarding glucagon's 
role in the hyperinsulinemia observed. Insulin resistance is not a 
likely explanation for these data in view of the results of the earlier 
studies of RES depression which demonstrated: 1) a decreased resistance 
to lethal insulin-induced hypoglycemia (table 1) (52, 55, 142, 144, 263~ 
2) an enhanced hypoglycemic response to exogenous insulin (52, 142), 3) 
increased glucose tolerance (table 2) (144), 4) increased glucose oxida-
tion (56, 134, 144) and utilization (188, 363, 364) and 5) decreased 
gluconeogenesis (56, 84, 140, 144, 145, 146, 188, 225, 291). Since the 
RES, especially the Kupffer cells, normally clear the blood of endotoxin 
(18, 20, 23, 41, 44, 53, 101, 129, 171, 179, 192, 196, 257, 274, 323, 
350, 353, 370), RES hypofunction may foster an endotoxemia (41, 101, 257) 
L'''ich would produce the alterations in glucose metabolism and insulin 
regulation seen with RES depression. Unfortunately this possibility 
cannot be tested as there is currently no satisfactory method of assay-
ing minute quantities of endotoxin in biological fluids. The older 
bioassay method to detect serum endotoxin was done using RES depressed 
animals (53, 135) and the limulus lysate test was reported to have no 
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clinical usefulness for detection of endotoxemia (117). 
In order to verify that the hyperinsulinemia was a concomitant of 
RES depression, blood samples were taken at 18 hours after administra-
tion of a blocking dose of colloidal carbon. Several workers have 
noted that from about 18 hours through 4 days after carbon blockade, 
there was a recovery of RES function to either a normal or heightened 
level of endocytic activity (22, 38, 103, 205, 259, 301, 309, 369). 
Table 5 and figure 5 show that at 18 hours after carbon blockade, serum 
insulin levels were not significantly different from control levels. 
The serum glucose levels and I/G ratios were also similar in the 3 
groups. The fact that serum insulin levels were normal when the RES 
function should have been returning to normal along with the preceding 
demonstration of hyperinsulinemia during RES depression divorced from 
a shock episode support the existence of a relationship between altered 
reticuloendotheilial systen1 function and insulin regulation. 
Proposed Role of the Reticuloendothelial System in Insulin Regulation. 
This study was performed to investigate a relationship between 
altered RES function and insulin regulation. In the two models of RES 
depression that were utilized, colloidal carbon blockade and acute lead 
treatment, both a functional and an actual hyperinsulemia were demon-
strated. These results suggested a possible role for the RES, particu-
larly the Kupffer cells of the liver, in the modulation of insulin level~ 
The hepatic macrophages normally are the principal endocytic cells 
of the body as evidenced by clearance studies (36, 179, 276, 309) and 
may also be equally important in the metabolism of the body. Some of 
the many metabolic, degradative and secretory functions of macrophages 
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were discussed in the literature review. What follows is a proposition 
that the hepatic macrophages may participate in the control of glucose 
homeostasis via regulation of peripheral insulin levels by the pinocy-
tic uptake and degradation of insulin. 
All the insulin-rich pancreatic venous effluent enters the portal 
vein and then passes through the liver before reaching the other tissues. 
During one trans-hepatic passage, Field, Mortimore and others have re-
ported that 40 to 50% of portal venous insulin is removed (47, 133, 202, 
236, 237), making the liver the chief site of insulin extraction in the 
body (47). In support of this statement, hyperinsulinemia has been 
detected in cirrhotic patients with portal-systemic shunting of blood 
and after portocaval anastomosis (197, 294, 297). Johnston et al. have 
presented data suggesting that cirrhosis of the liver causes a peri-
pheral hyperinsulinism by decreased hepatic insulin degradation and not 
increased insulin secretion (197). Both hyperinsulinemia or elevation 
of the I/G ratio have also been noted in cases of fulminating hepatitis 
(131, 282). However, despite the numerous investigations of hepatic 
insulin handling, the Kupffer cells have not been considered although 
they comprise about 33/~ of liver cells (31). Past investigators of 
insulin extraction and degradation tended to regard the liver as a 
homogeneous organ composed of only parenchymal cells since they were 
the largest cell population in the liver (31) ~'Jhich was studied lr!_ toto. 
Early experiments tested the ability of the liver and other tissue 
homogenates to degrade insulin by rendering isotopically labeled insu-
lin trichloroacetic acid-soluble (63, 116, 215, 322, 327, 361 ). These 
studies resulted in the recognition of two types of insulin-degrading 
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enzymes. One type is glutathione-insulin transhydrogenase (GIT) (63, 
209, 232, 322, 326, 327, 335, 336, 340), which requires reduced gluta-
thione or other thiol compounds (64, 335) to reduce the disulfide bonds 
of insulin, resulting in the separation of the A and B chains. The 
other type of enzyme includes the insulin proteases, which proteolytic-
ally degrade the polypeptide chains (50, 57, 215, 322, 337). Two 
studies on the tissue distribution of insulin degrading enzymes demon-
strated that the liver possessed a high content of both GIT and insulin 
protease (63, 215). Generally there was an inverse relation between 
tissue insulin sensitivity and tissue insulin-degrading activity (63). 
The exact location of the insulin degradation process remains 
controversial. Plasma membrane-bound insulin-degrading activity has 
been reported (155, 181, 252, 338) but may be an artifact of cell frac-
tionation (338). However the insulin-degrading enzymes are primarily 
intracellular (50, 57, 173, 181, 215, 322, 337). This results in a 
paradox in that the standard model for insulin action at the cellular 
level entails reversible binding to an external membrane receptor pro-
tein resulting in i ntracell ul ar changes vi a "second messengers" (88, 
169, 204, 218) with the bound insulin remaining undegraded (155). How-
ever Cuatrecasas• clever study to prove that insulin interaction with 
superficial cellular receptors initiated insulin•s metabolic effects 
(88) has been disproven. The insulin-sepharose complex that he utilized 
has since been shown to dissociate into a super-active free form of in-
sulin when in contact with biological materials (169, 328). Isolated 
intact cells have also been shown to degrade insulin (62, 181, 219, 252, 
318, 339), the amount of degradation being directly related to the 
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amount bound to the receptor (318). Thus the receptor may function in 
bringing insulin into contact with the degrading systems which then 
terminate the hormonal signal at the cell membrane (308, 318). 
r~isbin et ~- found that insulin extraction by the isolated per-
fused rat liver cannot be explained by the properties of the previously 
described insulin-degrading enzymes (233). Others have noticed that 
there is a lag between the initial removal and subsequent degradation 
of insulin by both isolated perfused rat liver (194, 236, 319) and rat 
hepatocytes (318) that was not seen in the studies using broken-cell or 
isolated enzyme preparations (50, 57, 63, 64, 88, 155, 173, 209, 215, 
232,252,322,326,327,335,336, 337, 338, 340, 361). Also factors VJhich 
are thought to decrease the mobility of cell membrane components, such 
as decreased temperature (2, 83, 240, 273) and concanavalin A (29), have 
been shown to depress insulin degradation (236, 318, 319), with little 
interference with insulin extraction (236), binding (319) or degradative 
enzyme reactions (236). Numerous reports of intracellular localization 
of labeled insulin in intact cells or tissues, after iv injection or in 
vitro addition, exist (17, 46, 109, 116, 157,169, 194, 221,232, 252, 
307, 322, 366). Recent studies have uncovered intracellular insulin 
receptors (169, 191), implying that insulin may in fact enter cells and 
bind to subcellular organelles. Several investigators have therefore 
proposed that the missing link between extracellular binding and intra-
cellular degradation could be the entrace of insulin into the cell (194, 
221, 307, 322), perhaps by pinocytosis (15, 169, 170, 232, 308). 
The preceding review represents the state, of the art as far as 
published research papers on insulin extraction and degradation are con-
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cerned. It may be that Kupffer cells are the missing link in the ex-
planation of hepatic insulin extraction and degradation. As was men-
tioned before, these cells are the first hepatic cells to be in contact 
with insulin secreted by the pancreas. Kupffer cells can carry out all 
the various endocytic processes i.e. phagocytosis, macropinocytosis and 
micropinocytosis (239, 240, 242) which formed the basis for their 
classification into the mononuclear phagocyte system with other endocytic 
RES cells (158). It seems reasonable to infer that the Kupffer cells 
may participate in hepatic insulin metabolism via a pinocytic mechanism. 
Although insulin receptors have not been identified on hepatic macropha-
ges as of yet, they have been found on both monocytes (154, 203, 204, 
250, 254, 255, 286) and splenic macrophages (13, 271). Since macrophage 
glucose metabolism appeared to be insulin independent, (165, 174, 264), 
one is left with the paradox of avid insulin binding without the 
familiar metabolic consequences. Insulin had been shown to cause some 
less orthodox effects in lymphocytes such as increased ATPase activity 
(177) and augmentation ofT-lymphocyte-mediated cytotoxicity (315). In 
fact T-lymphocyte insulin receptors appear on the cell concommitant with 
cellular transfor'mation and immune activation (217, 315). Insulin would 
thus seem to be involved in regulation of immunological functions. Bar 
and associates have demonstrated that insulin caused inhibition of anti-
body dependent cytotoxicity in spleen macrophages (13). This effect may 
be mediated by the insulin modulation of macrophage Fe receptor expres-
sion (271). 
The reports of Rhodes (271) and Baret~- (13) both point indirectly 
to a possible insulin induction of endocytosis which could be instru-
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mental to the subsequent degradation of insulin by macrophages, 
especially the Kupffer cells. Stossel et ~· did report that insulin 
slightly stimulated the phagocytic rate of polymorphonuclear leukocytes 
(314). Insulin appeared to enter adipose tissue cells (15) and renal 
proximal tubule cells by endocytosis (46). Incubation of fibroblasts 
with insulin resulted in the formation of numerous microvilli on the 
cell surface (128, 198). It could be argued that insulin was merely 
promoting the growth of the fibroblasts and causing a pleiotypic 
response (187) but insulin has been shown to promote microtubule assem-
bly in cells (262, 300) without significant effects on protein synthesis 
(262). Microtubules and microfilaments probably mediate changes in cell 
membrane conformation, especially those associated with endocytosis 
(246, 310, 311, 312, 313). The insulin molecule has minimum solubility 
in body fluids at pH= 5.0, suggesting that it exists as an anionic 
molecule at physiological pH (162). Cohn has mentioned in several 
papers that anionic molecules tended to stimulate pinocytic activity in 
macrophages {71, 72, 76, 113). Thus insulin may induce endocytosis, 
probably pinocytosis in macrophages. 
Heightened endocytic activity has been shown to result in a deple-
tion of macrophage cellular membrane components including receptors 
(73, 239, 266, 269, 354, 355). It is then logical to suggest that 
insulin receptors may also be internalized during the endocytosis of a 
colloidal overload such as a blockade-inducing dose of carbon. The 
down-regulation of insul-in receptors, characterized by a reciprocal 
relationship between insulin concentration in the extracellular fluid 
and the concentration of cellular insulin receptors (164), may involve 
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internalization of the insulin-receptor complex (204, 308). Kahn et a l . 
have discussed the possibility of a pinocytic uptake of the receptor with 
its subsequent enzymatic degradation inside the cell (204). Inhibitors 
of protein synthesis prevented the receptor degradation (204). It seems 
probable that these enzymes may be contained in lysosomes which are 
abundant in Kupffer cells (2, 25, 241, 299). Steiner has proposed that 
insulin enters intact cells perhaps by endocytosis of an insulin-recep-
tor complex which could then dissociate, allowing the hormone or its 
fragments to act directly on cellular components (308). Grisolia and 
~·Jallace found hepatic lysosomes to be rich in both GIT and 11 insulin 
specific protease 11 (173) lending support to a lysosomal theory of degra-
dation of insulin. Human leukocytes were shown to contain GIT (65), so 
monocytes and other RES cells may possess insulin degrading activity. 
During the induction of a diabetic state with streptozotocin, wandering 
macrophages disposed of the remaining insulin granules within the pan-
creas (200, 201). Kupffer ce 11 s have also been reported to take up and 
degrade insulin antibody complexes (157, 347) and to concentrate labeled 
insulin (17, 307, 366). A preliminary report by Wagle (347) that 11 much 
higher degradation of insulin was found with Kupff'r cells than with 
hepatocytes, 11 which appeared after this study was completed, may confirm 
the participation of Kupffer cells in the hepatic degradation and thus 
modulation of insulin levels. 
Even if Kupffer cells are proved to degrade insulin~ vitro further 
experimentation will be needed to elucidate the exact mechanisms of the 
cellular uptake and enzymatic activites involved. In order to deter-
mine whether and what type of endocytosis is involved, studies using 
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isolated Kupffer cells and various inhibitors of endocytosis should be 
fruitful. Since insulin is a relatively small molecule, and in solu-
tion, the most likely mechanisms for its uptake by macrophages would be 
micropinocytosis, which is inhibited by lmv temperature or decreased 
membrane fluidity, or perhaps macropinocytosis, which is inhibited by 
cytocha 1 as in B and agents interfering with metabolism m~ protein synthe-
sis (2, 70, 72, 113, 240). Since Terris and Steiner have reported that 
concanavalin A depressed insulin degration in the isolated perfused rat 
liver (319), these results may be reinterpreted to support a pinocytic 
entrance of insulin into the Kupffer cell with secondary lysosome forma-
tion and degradation. Edelson and Cohn reported that concanavalin A, 
rather than inhibit endocytosis (29), stimulated pinosome formation but 
prevented fusion of the vesicles with lysosomes (110) rather than 
decreasing membrane fluidity (29, 319). 
Studies on isolated Kupffer cells should also be done to confirm 
whether a GIT-like enzyme for degrading is present. Glutathione, which 
is utilized in the GIT reduction of insulin, is ubiquitous in the body 
tissues and is found in high concentration in insulin-degrading tissues 
(346). Glutathione has been shown to be essential to alveolar macro-
phage metabolism (344). It is probable that macrophages, including 
Kupffer cells, do produce glutathione and other thiol containing com-
pounds (66) which could be used to degrade insulin (64, 335). Since 
lead inhibits enzyme systems via combination with sulfhydryl groups 
(182) it may interfere with the activity of GIT and insulin degradation 
at the molecular level in addition to causing decreased RES endocytic 
function. Cysteine and other sulfhydryl compounds protected rats from 
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lead acetate sensitization to endotoxin (34, 79, 80), perhaps by main-
taining the normal function of the insulin degradative system. 
To verify that RES depression is causing a diminished hepatic ex-
traction and degradation of insulin,studies should be performed using 
the isolated perfused liver. In shock, which is accompanied by RES 
depression, i!!_ vivo measurements of insulin clearance showed a prolonga-
tion of the half-time of insulin disappearance (61, 87, 226); however, 
these results are complicated by a possible decrease in blood flow to 
the liver (40). The in vivo cardiovascular variable would be eliminated 
in the isolated organ preparation which would also maintain the Kupffer 
cells in their normal condition lining the sinusoids. There should also 
be studies done to determine whether macrophages, especially the hepatic 
Kupffer cells, may have a role in insulin regulation by influencing 
pancreatic insulin secretion. Leukocytic endogenous mediator is a pro-
tein reported to be produced during infection by macrophages, as well 
as leukocytes (19, 166, 206, 260). This substance has been shown to 
cause elevations in pancreatic insulin via a central nervous system-
mediated response (166). Much clarification of the nature and effects 
of this substance is still needed. 
The results of the present study and all the above evidence do sug-
gest a potential role for the hepatic Kupffer cells in insulin regula-
tion. Although not definitively proven, the macrophages of the RES may 
interact with insulin not only in terms of regulation of the immune 
response (13, 271) but by regulating peripheral insulin levels. The 
Kupffer cells seem especially well-suited for a role in modulating the 
amount of insulin presented not only to the peripheral tissues but to 
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the parenchymal cells of the liver which control blood glucose levels. 
By their maintenance of circulating insulin concentrations which pro-
mote a normoglycemic state in the organism, the Kupffer cells would 
also insure their own substrate supply. Consequently, the Kupffer and 
parenchymal cells of the liver may function together to insure glucose 
homeostasis. 
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Conclusions 
In summary, the present study demonstrated that: 
1. depression of RES function by acute lead treatment sensitized rats 
to lethal insulin-induced hypoglycemia; 
2. RES depression by acute lead administration increased glucose 
tolerance; 
3. RES depression by either colloidal carbon blockade or acute lead 
administration produced an elevation of both basal and glucose-stimulat-
ed serum insulin levels. 
Therefore it is concluded that there is a relationship between 
altered RES function and insulin regulation since RES depression result-
ed in a functional and actual hyperinsulinemia. These data also suggest 
a novel role for the RES in the modulation of insulin levels, perhaps by 
participation in the hepatic extraction and degradation of insulin. 
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